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ABSTRACT
The region Ilpl3-pl5 on the short arm of chromosome 11 (lip) has 
been implicated in the initiation or progression of several human 
malignancies including the embryonic rhabdomyosarcoma Wilms' 
tumour, bladder, renal cell and ovarian carcinoma. In this study, 
Fluorescence In Situ hybridisation (FISH) was used to identify 
the nature of a chromosome llp+ abnormality present in two 
ovarian carcinoma cell lines after conventional cytogenetic 
techniques had failed to elucidate the chromosomal origin of the 
abnormality. Using whole chromosome library probes, the 
abnormality in cell line UW0V2 was found to be composed entirely 
of chromosome 3 material representing the translocation 
t (3;11) (pl2-14;pl5). In the protein-free subline UW0V2(Sf), the 
abnormality was found to consist of the complex translocation 
t (3;8; 11) (pl2-14 ;q22-24;pl5) . It is possible that the involvement 
of chromosome 8 in this translocation was a cell culture 
phenomenon. Other structural and numerical abnormalities 
elucidated with FISH in cell line UW0V2(Sf) included lq+, +5, +7, 
7q-, 8q+, +12, +14, 14q+, -15, 16q- and -18.
Using FISH together with the gene probe pSB|5 and the CEPH YAC 
probes 892g9, 785e5, 847al2, 954f4, 966e8 and 845a3, the 
breakpoint region on chromosome 11 in the _ two cell lines was 
narrowed down and mapped to the region Ilpl4.3-pl5.1 lying 
between probes 966e8 (D11S902) and 845a3 (D11S899). This 
represents a physical distance of approximately 1 Mb. The 
breakpoint in the two cell lines appeared to involve the same 
region on llplS.l.
In a separate study, three epithelial ovarian tumour specimens 
and four ascitic fluid specimens were obtained. Tumour specimens 
T2 and T4 and ascitic fluid specimens AF-1, AF-2 and AF-3 were 
all cytogenetically uninformative. Cytogenetic analysis of 
specimen T5 revealed a single clonal abnormality involving a 
deletion in the region 6q21. Ascitic fluid specimen AF-5 yielded 
cytogenetically normal metaphases. Both specimens were 
hypodiploid and revealed a cytogenetically normal chromosome 11. 
Using FISH and CEPH YAC probes 966e8 and 845a3, no abnormalities 
were detected in the region llpl4.3-pl5.1 in these two specimens 
but one cannot rule out the possibility of submicroscopic 
abnormalities lying within the region between these probes. From 
this study we speculate that chromosome 6 abnormalities may be 
important in the initiation of these tumours.
From the results obtained with cell lines UW0V2 and UW0V2 (Sf) we 
speculate that the chromosome 3 abnormalities were an early event 
in the evolution of these tumours while the chromosome 11 
abnormality was a later event. Little is known about the region 
llpl4.3-pl5.1 and very few disease loci have been assigned to 
this region, however, we may speculate that this region harbours 
a tumour suppressor gene or an oncogene whose disruption or 
activation is critical to the pathophysiology of ovarian 
carcinoma and other genitourinary cancers.
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SECTION 1.0
INTRODUCTION
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1.1 THE BIOLOGY OF OVARIAN CARCINOMA
Ovarian carcinomas encompass a wide range of tumour types the 
commonest being the epithelial tumours. The human ovary is a 
complex organ with two major normal physiological functions; the 
production of steroid hormones and the timely release of the 
ova, that is, ovulation. Embryologically, the ovarian surface 
epithelium is related to the epithelial lining of the fallopian 
tubes, endometrium and endocervix. The ovarian surface 
epithelial cells are a modified peritoneal mesothelium which 
originates from the same coelomic epithelium which invaginates 
laterally to the gonads during embryonic development forming the 
paramesonephric or mullerian duct system of the embryo. This 
process also results in the formation of the fallopian tubes, 
endometrium, uterus and part of the vagina. These epithelia and 
the ovarian surface epithelium are thus closely related.
During the fourth or fifth month of foetal development, the 
ovarian epithelial cells undergo intense mitotic activity 
possibly as a result of hormonal stimulation (Gondos
1975) . The presumptive granulosa cells of the ovary form as a 
result of downgrowths of this surface epithelium thus the 
coelomic epithelium has the capacity to differentiate along 
several lines. The striking number of phenotypes found 
associated with ovarian carcinomas may be explained by this 
differentiation potential displayed by the coelomic epithelium.
The majority of ovarian tumours are thought to arise from the 
ovarian surface epithelial cells. These common epithelial 
tumours display a range of histological features which enable 
them to be classified according to their histological 
similarities with the epithelial components characteristic of 
different mullerian structures. The most common of these 
epithelial tumours are the serous, mucinous and endometroid 
types and consist of biologically and morphologically benign 
neoplasms called cystadenomas as well as malignant 
cystadenocarcinomas.
Several hypotheses have been proposed to explain the development 
of ovarian carcinomas. These models are purely speculative and 
although animal systems have been looked at, little work on 
human systems has been undertaken. The most popular hypothesis 
is based on evidence that during the course of reproductive 
life, the ovarian germinal epithelium may become entrapped 
within the ovarian stroma due to continuous ovulation, resulting 
in the formation of epithelial inclusion cysts. This process 
places the ovarian surface epithelial cells in close proximity 
to the growth factor and steroid hormone producing components of 
the ovary. Subsequently, this process may induce oncogenic 
factors which cause the benign epithelium to undergo malignant 
transformation (Cramer et al.1983).
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Another hypothesis is that the surface epithelium is stimulated 
into growth and repair during ovulation. Frequent ovulation 
would thus imply frequent cycles of cell division by these cells 
which increases the risk of mutation during DNA replication 
(Fathalla, 1971).
It is unknown whether or not these carcinomas arise de novo or 
through clonal expansion from pre-existing cystadenomas, that 
is, if the benign epithelium leads directly to invasive 
carcinoma or passes through stages of benign/borderline 
carcinoma. Puls et al. 1992, identified areas of benign 
epithelium adjacent to borderline or malignant epithelium in 
the majority of mucinous and serous ovarian cystadenocarcinomas 
which suggested that certain benign or borderline tumours may be 
precursors to invasive carcinomas. Bourne et al.1991, showed 
that malignant transformation of benign epithelial ovarian 
tumours was increased in women with a genetic predisposition 
while Dubeau et al.1993 also showed areas of benign growth 
adjacent to malignant growth.
Although the relationship between benign and malignant 
carcinomas has been investigated, the genetic evolution of these 
tumours has remained elusive. By the time these tumours are 
detected, they usually exhibit complex structural and numerical 
abnormalities and thus it is difficult to distinguish between 
early and late genetic events.
1.1.1 Chromosomal Translocations
Cancer cells usually harbour chromosomal abnormalities the 
complexity of which increases with an increase in
tumourigenicity. Such abnormalities may be inherited that is, 
carried within the germline of an individual or they may be 
acquired sporadically resulting in a somatic mutation. They may 
also be present in different forms as a result of certain 
genetic events such as translocations, deletions, amplifications 
and numerical abnormalities.
Chromosomal translocation involves the transposition of a 
chromosome segment to a new location within the genome. 
Translocations are usually specific for the type of malignancy 
such as leukaemias, lymphomas, sarcomas and mesenchymal 
neoplasms. They occur at nonrandom sites and may involve genes 
and oncogenes relevant to the pathophysiology of the disease. 
The translocation event may lead to the activation of a gene or 
cellular oncogene resulting in the overexpression of that gene 
product. Two examples of this are described here. The t(ll;14) 
and t (14;18) in lymphomas where the bcl-1 and bcl-2 genes 
juxtapose respectively with the immunoglobulin heavy chain 
promoter sequences results in the overexpression of these two 
genes respectively. (Reed, 1994). The second group of
translocations result in the production of chimaeric proteins. 
Here, the recombination event fuses two genes, one of which is
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always a transcription factor. In the t(l;19) seen in acute 
lymphoblastic leukaemia, the E2A transcription factor gene on 
chromosome 19 fuses with the PBX homeobox gene on chromosome 1 
(Cleary, 1991) . The resulting chimaeric protein acts as a novel 
transcription factor interfering with proliferation and survival 
of lymphoid hematopoietic precursors. A translocation event may 
also result in the inactivation of an anti-oncogene or tumour 
suppressor gene resulting in tumourigenicity.
The translocation event may also lead to the activation of 
certain cellular proto-oncogenes. Proto-oncogenes are known to 
code for many components of the signalling pathways which carry 
growth stimulatory messages from the local environment to the 
nucleus. These components include growth factors, cell surface 
receptors, cytoplasmic signal mediators and transcription
factors within the nucleus. The activation of certain
protooncogenes such as c-erbB-2f c-fms, c-myc and K-ras occurs 
relatively frequently in ovarian tumours but appears not to be 
related to prognosis.
The two most widely studied oncogenes in ovarian cancer are the 
K-ras and HER-2/neu oncogenes. Human ovarian cancers have 
demonstrated over-expression of the HER-2/neu gene which codes 
for a growth factor receptor similar to the epidermal growth 
factor (EGF) receptor. Over expression of this gene was found to 
be caused by gene amplification in this locus and was associated 
with poor disease prognosis (Berchuck et al.1990).
Mutations in the ras family of proto-oncogenes have been 
identified in many human adenocarcinomas including lung, colon 
and pancreas. Point mutations in the ras proto-oncogene result 
in a mutant ras protein which is constitutively activated 
sending growth stimulatory messages. In ovarian carcinomas, K- 
ras mutations have been detected in borderline and invasive 
mucinous tumours. These mutations may represent an early event 
in the progression of malignancy (Toneriello et al. 1993; Mok et 
al.1993) and may indicate an event in the transition between 
borderline and invasive carcinomas.
The translocation event may also result in the inactivation of 
anti-oncogenes or tumour suppressor genes (TSGs). With the 
development of chromosomal banding techniques, the normal and 
abnormal appearance of chromosomes could be discerned in a 
process known as ’karyotyping*. This process facilitated the 
identification of regions of chromosomes that were deleted, 
duplicated or translocated. The link between such chromosomal 
abnormalities and the presence of a malignant phenotype lent 
support to the hypothesis that cancer was a disorder of the 
chromosomes. Since the 1960's, there has been increasing 
evidence to suggest that fusing normal cells with malignant 
cells resulted in some fused cells reverting to a less malignant 
phenotype (Harris et al.1969). Later, with a technique known as 
microcell transfer, it was possible to demonstrate that the
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introduction of single chromosomes to tumour in vitro, resulted 
in the reversion of the malignant phenotype which suggested that 
these single chromosomes harboured differentiation inducing 
genes or tumour suppressing genes (Saxon et al.1986).
The discovery and cloning of the gene responsible for the 
paediatric eye tumour, retinoblastoma (RB) accelerated research 
into the discovery of genes responsible for suppression of the 
malignant phenotype. Retinoblastoma occurs in two forms: 
sporadic, where the tumour is unilateral and the condition is 
not inheritable; and familial, where usually bilateral tumours 
are seen and the condition can be traced through families. 
Knudson, (1971), proposed that two mutations were necessary for 
tumour formation that is, both alleles of the same unidentified 
gene were mutated. In the inherited form of the disease, 
children inherited a mutant allele and the second mutation 
occurred somatically whereas in sporadic cases, both mutations 
occurred somatically. This 1 two-hit hypothesis' explained why 
only cells with two mutant alleles developed into cancers while 
cells with one normal gene could suppress tumouri genes is. These 
studies led to the idea that tumour suppressor genes (TSG's) act 
recessively at the cellular level as opposed to oncogenes which 
act dominant to the wild type.
The techniques used in isolating the RB TSG serves as a model by 
which other TSGs may be assessed including those thought to be 
associated with ovarian carcinoma. Cloning of the RB gene 
depended on clinical and epidemiological data, cytogenetics, 
somatic cell hybrids, linkage analysis studies and loss of 
heterozygosity (LOH) studies.
The presence of minor interindividual sequence variations or 
polymorphisms in the human genome formed the basis for initial 
protocols in disease tracking. Probes recognising length 
polymorphisms (RFLP s) could be used to track RFPLs coinherited 
within a family. Somatic cell hybrids and the presence of 
hypervariable regions in the genome allowed the discovery of 
more probes which were linked to disease loci. Using this 
technique, the region within which the gene of question lay was 
considerably narrowed down and the tight linkage between 
anonymous, accurately localised markers and specific diseases 
could be shown.
The generation of DNA polymorphisms had another invaluable 
application. They could be used to study the differences between 
DNA extracted from tumours and that extracted from normal tissue 
where both tumour and constitutional DNA are studied under the 
same experimental conditions. The DNA is digested with 
restriction endonucleases to reveal the polymorphisms. The 
digested DNA is then resolved by electrophoresis on an agarose 
gel and transferred to a filter. The filter is then hybridised 
to radiolabelled probes of known localisation. The resulting 
autoradiographic pattern reveals the presence or absence of
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targeted alleles. If only one allele is present in the tumour 
sample while two copies are found in the normal tissue this is 
referred to as reduction to homozygosity, or loss of 
heterozygosity (LOH). In this way submicroscopic deletions, non­
disjunction with reduplication or mitotic recombination can be 
distinguished.
Chromosomal recombination normally occurs during meiosis where 
homologous chromosomes exchange sequences, but during mitotic 
recombination, if a chromosome contains a putative tumour 
suppressor gene (TSG), the chromosomes will be identical below 
the crossover point resulting in LOH and therefore any crossover 
centromeric to the TSG will result in homozygosity at that 
locus. Non-disjunction may also occur during mitosis and is 
characterized by paired chromosomes failing to separate at cell 
division. The resulting cell will have both chromosomes derived 
from the same parent and LOH will occur over the whole 
chromosome. Under the above models, a second mutation in the TSG 
or a deletion of the wild-type gene is not required.
In all cancers, mitotic recombination and non-disjunction appear 
to be the most common mechanisms of LOH. Terminal and 
interstitial deletions, gene conversions and translocations are 
less common, however if tumours present with these
abnormalities, they may precisely localise the position of a TSG 
rendering cloning of the gene more manageable. Cloning of a 
putative TSG using the above method may prove to be an arduous 
and laborious task (Foulkes, W.D.; Trowsdale, J., 1995).
1.1.2 Loss of Heterozygosity in Ovarian Carcinoma
Numerous studies on LOH in ovarian carcinoma have been presented 
and have been largely based on the protocol described by Cavanee 
et al. (1983). For the most part, these studies have detailed LOH 
on those chromosomal arms known to harbour TSGs but little work 
has been done on the TSGs themselves. The conclusion that the 
LOH on a particular arm can be accounted for by a known TSG is 
thus purely speculative. Foulkes et al.(1993) described a 
provisional allelotype for ovarian carcinoma based on a 
compilation of published data on LOH in ovarian carcinoma. 
Chromosome arms 6q, lip, 3p, 13q, 16q, 17q and 17p are regions 
of the genome that exhibit LOH and may contain TSGs important in 
the pathogenesis of ovarian carcinomas. Chromosome 17p and 17q 
show high rates of allelic imbalance and recently the breast- 
ovarian cancer gene (BRCA1) was assigned to the region 17ql2-21 
by linkage analysis (Easton et al.1993). This gene however, 
rarely contributes to ovarian tumourigenesis in common sporadic, 
non-familial cases (Merajver et al.1995;Trowsdale et al.1995) 
and thus another mechanism must exist in these cases.
Abnormalities involving the short arm of chromosome 11 (lip) 
have been extensively described in epithelial ovarian 
carcinomas. Deletions and unbalanced translocations involving
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the region Ilpl3-pl5 have been implicated in the development of 
the malignant phenotype (Pejovic et al.1992; Jenkins et al.1993; 
Thompson et al.1994). The chromosomal origins of these 
abnormalities could not be determined cytogenetically due to 
their complexity. Loss of heterozygosity studies have revealed 
certain loci spanning the region Ilpl5.1-pl5.5 to be deleted. 
Gallion et al.1992, demonstrated LOH at the HRAS1 locus 
(llpl5.5) in the majority of invasive tumours but not in 
borderline tumours which confirms previous studies by Zheng et 
al.1991 and Lee et al.1989 who noted that HRAS1 losses were most 
common in high grade or metastatic tumours suggesting that lip 
loss may be involved with later steps in ovarian tumourigenesis. 
Kiechle-Schwarz et al.1993 using DNA recombinant technology 
together with Southern blotting and polymorphic probes to the 
regions HRAS1 (llpl5.5), INS (llpl5.5), PTH (Ilpl5.2-pl5.1) and 
CALCA (llpl5.2-15.1) found LOH in informative cases of 47.5% 
reduction to homozygosity. The study suggested the presence of a 
TSG in the region of the HRAS1 locus that was important in 
tumour progression. Later studies showed similar findings 
(Weitzel et al.1994).
Allelic loss on chromosome lip thus correlated with a clinically 
more aggressive disease possibly reflecting a progression from 
benign to malignant or low grade to high grade state. Although 
the above loci studied have been informative, one cannot rule 
out the possibility of there being other regions on lip 
harbouring a TSG(s) which may contribute to the mechanism of the 
disease.
1.1.3 The Role of TSGs in Ovarian Carcinoma
Little is known about the role of many of the known TSGs in 
ovarian carcinoma and no TSG specific to this cancer has been 
isolated. The reasons for this are several. Firstly, despite the 
knowledge that heritable forms of ovarian cancer did exist, it 
has only recently been acknowledged that ovarian cancer formed 
part of a group of familial cancer syndromes. Secondly, the 
pathogenesis of ovarian carcinoma is not fully understood and it 
is not known if tumourigenesis occurs in a stepwise progression 
from benign adenoma to malignant carcinoma or if another 
mechanism exists. Thirdly, by the time that ovarian carcinomas 
are detected, they usually present with karyotypes exhibiting 
complex structural and numerical changes and it has not been 
possible to find chromosomal areas consistently involved in all 
tumours.
The tumour suppressor gene P53 on chromosome 17p has been 
studied in some detail in ovarian carcinomas. Growth suppression 
by this gene may be two-fold, firstly, p53 binds to and in turn 
suppresses various transcription factors including those that 
bind to TATA elements. Secondly, it transcriptionally activates 
the expression of a number of genes which encode proteins that 
can suppress cell division (Levine et al.1991). p53 Mutations in
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ovarian cancer may be a later event in tumour progression as 
mutations have not been detected in borderline cases 
(Kupryjanczyk et al. 1995) . Abnormalities observed, reveal a 
predominance of transitional mutations as well as trans vers ions 
and microdeletions (Kohler et al.1993).
Mutations at the RB gene locus on chromosome 13q have also been 
investigated as a candidate TSG for ovarian cancer, however, 
inactivation of the RB gene leading to abnormal RB protein 
expression is a rare event in ovarian cancer (Dodson et al. 1994) 
and thus its role in ovarian tumouri genes is remains to be 
elucidated.
1.1.4 Candidate Genes on Chromosome lip
The pathophysiology of several human malignancies is thought to 
be linked to the inactivation or loss of a putative TSG on 
chromosome lip.This region is known to harbour TSGs as revealed 
by microcell fusion studies conducted by Weismann et al.1987. 
The region llpl5 is specifically of interest as similar studies 
have shown that it has tumour suppressor activity (Dowdy et 
al.1991) .
Chromosomal abnormalities involving Ilpl3-pl5 loci have been 
demonstrated in: breast carcinoma (Winqvist et al. 1993) who 
implicated the region between the TH and HBB genes at llpl5.5; 
prostate cancer where two prostatic carcinoma metastasis 
suppressor genes have been localised to the region Ilpl2-pl3 
(Isaacs et al.1992) and hepatocellular carcinoma (Wang et 
al.1988) (figure 1).
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Figure 1: A map of the short arm of chromosome 11 (lip) 
indicating the location of candidate genes in the region llpl3 
and llpl5
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The region Ilpl3-pl5 has also attracted great interest as it 
harbours two TSG loci implicated in the development of the 
embryonal rhabdomyosarcoma Wilms1 tumour (WT) and Beckwith- 
Wiedemann syndrome (BWS) . Wilms* tumour of the kidney or
nephroblastoma, is a tumour of embryonic origin and is derived 
from metanephric blastermal tissues of the developing kidney 
that have failed to undergo the normal maturation process. The 
condition is associated with a high incidence of congenital 
abnormalities including Wilms* tumour development, genitourinary 
abnormalities and mental retardation (WAGR) syndrome (Breslow et 
al.1982) .
Cytogenetic studies on Wilms' tumour initially revealed an llp- 
in the region llpl3 (Kaneko et al.1981) and subsequently, 
variations in lip have been reported for approximately 25% of 
all WTs studied. The breakpoints of these structural changes 
involved the regions llpl3 and llpl5 and thus it was speculated 
that two WT loci, one in each of these regions plays a role in 
this disorder. The WT TSG WT1 has been mapped to the region 
llpl3 (Gessler et al.1990) and a second putative WT TSG has also 
been mapped to the region llpl5 and may be related to the 
childhood BWS (Koufos et al.1989).
Beckwith Wiedemann syndrome, an autosomal dominant condition, is 
characterized by numerous growth abnormalities including 
unilateral exomphalos, macroglossia and gigantism. These 
patients show a predisposition to development of several 
childhood tumours including WT, adrenocortical carcinoma and 
rhabdomyosarcoma. Genetic evidence shows that the region llpl5.5 
distal to the HBB locus is associated with BWS (Henry et 
al.1993) . This region also contains the three contiguous genes 
IGF-II, HI 9 and INS. These genes have been shown to be 
imprinted, that is both alleles being derived exclusively either 
maternally or paternally (Ferguson-Smith et al.1993; Ohlsson et 
al.1993) . Genomic imprinting has attracted great attention 
because of the connection between abnormalities in the
imprinting process and tumourigenesis. Imprinting of the IGF-II 
gene was first described in mice. Here, partial trisomy llpl5 
resulted from paternal isodisomy where the IGF-II gene in the 
mouse was paternally imprinted resulting in a growth deficiency. 
Those mice inheriting the maternal allele were normal (DeCharia 
et al. 1991). Several human malignancies reveal a duplicated set 
of either paternal or maternal chromosomes such as that found in 
dermoid tumours of the ovary and hydatidiform moles. Oncogenesis 
however may also occur when the normal imprinting process is 
disrupted and a normally silenced imprinted gene is expressed. 
In Wilms' tumour, the IGF-II gene is found to be overexpressed 
and these tumours have been shown to synthesise increased 
amounts of IGF-II. In 1993, Feinberg showed that the expected 
imprinting of IGF-II and HI 9 in WT was disrupted indicating a 
"relaxation" of the imprinted allele. The expression of HI 9 
which is believed to have TSG functions, has been shown to be 
linked to IGF-II expression where a cell expressing increased
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amounts of IGF-II expresses decreased amounts of HI 9 tumour 
suppressor product leading to a possible scenario for 
tumourigenesis. Some BWS patients have also demonstrated 
abnormalities of IGF-II imprinting in a number of cells. Loss of 
IGF-II imprinting has not been restricted to WT and BWS. Vu et 
al.1995 demonstrated complete or partial relaxation of IGF-II 
imprinting in uterine leiomyosarcomas and Gicquel et al.1994 
suggested a role for IGF-II and the region llpl5 in 
adrenocortical tumours.
The role of genomic imprinting in relation to ovarian carcinoma 
remains to be elucidated. Because mutations in the WT1 gene are 
not a prerequisite for tumourigenicity in certain WT patients 
(Slater et al.1992) another region possibly on 16ql3 may 
predispose some of these patients to malignancy (Newsham et 
al. 1995) . This leads one to speculate on the role of WT1 and of 
the region llpl5 in WT as possibly playing a role in the 
progression of these tumours. This hypothesis would strengthen 
the link between the progression of ovarian tumours and Wilms* 
tumour.
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1.2 Fluorescence in situ Hybridisation (FISH)
1.2.1 Background
In 1969, Gall et al. described a method for the visualisation of 
specific nucleic acid sequences in morphologically preserved 
chromosomes, cells and tissue sections, using isotopically 
labelled RNA probes. This procedure came to be known as in situ 
hybridisation. Such a technique was able to localise abundant 
sequences such as those of DNA in polytene chromosomes or highly 
repetitive sequences on metaphase chromosomes. Molecular cloning 
methods were unavailable and thus in situ hybridisation was 
restricted to those sequences that could be purified and 
isolated by conventional biochemical methods for example, mouse 
satellite DNA, viral DNA and ribosomal RNA. There were however 
several drawbacks with this method of in situ hybridisation the 
main ones being that the protocols were long and laborious and 
that abundant target sequences were detected with relatively low 
resolution.
In 1981, Harper et al. described a method whereby DNA sequences 
of only a few base pairs in length could be detected on 
metaphase chromosomes. Such a technique required fairly short 
autoradiography exposure times coupled with statistical 
analysis. The technique also allowed the mapping of genes 
relative to chromosomal bands by combining 
hybridisation/detection protocols with standard binding 
protocols and therefore, this system became an integral part of 
genome mapping protocols.
Although its progress has been substantial, isotopic in situ 
hybdridization is restrictive due to long autoradiographic 
development times, extensive and arduous statistical analysis, 
the emitted isotopic signal has to be captured with an emulsion 
overlay which limits mapping precision and the track of 
radioactive decay also limits spatial resolution. The cost of 
the reagents and methods for the disposal of such radioactive 
waste has also become a significant problem.
In order to overcome the limitations of isotopic or radioactive 
in situ hybridisation, methods for non-isotopic in situ 
hybridisation were devised. In 1977, the use of an antibody 
system for the detection of RNA-DNA hybrids was described, and 
Broker et al.1978 described a biotin-avidin system to detect in 
situ hybridisation by electron microsocopy.
From these pioneering studies, two methods of non-radioactive in 
situ hybridisation emerged. These methods involved the use of 
fluorochromes as part of the detection system. The direct method 
involved the direct labelling or introduction of fluorochromes 
to DNA probes.
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The indirect method involved the labelling of DNA probes with a 
modified hapten such as biotinylated deoxyuridine triphosphate 
(dUTP) . This biotinylated dUTP replaced thymidine during nick 
translation of a DNA probe and detection of the desired sequence 
could be achieved using antibodies against the desired hapten 
coupled to a fluorochrome (Langer et al.1981).
The reliability of both methods depended on the modified probes 
ability to withstand and not interfere with the hybridisation 
and post hybridisation procedures. Since then, several hapten- 
antibody systems for use in Fluorescence in situ hybridisation 
were produced including the digoxigenin system (Boehringer 
Mannheim, Germany). Other chemical modification schemes include 
mercuration, sulphonation and acetylaminofluorescence (Lichter 
et al. 1991a). The two systems most widely used are the biotin 
and digoxigenin systems.
In situ hybridisation on cytological material is considerably 
more difficult than that performed on membrane filters and 
Lawrence et al.(1988) described three main criteria that should 
be met for maximum results:
1) the target sequence should remain preserved and 
accessible to the probe
2) hybridisation kinetics should be standardised so as to 
allow the probe to bind to specific target sequences 
without non-specific binding to biological material
3) probe detection should be such that a signal is evident 
with minimal background noise
Biotinylation of DNA during nick translation was first 
described by Langer et al.(1981) . This was accomplished through 
the synthesis of the allylamine derivative of dUTP which could 
be biotinylated using the active N-hydroxysuccinimide ester of 
biotin. The ability of anti-hapten antibodies to detect the 
biotin moeity in DNA duplexes is dependent on the length of the 
spacer arm. Several other biotinylated precursors have since 
been developed and have proved to be more efficient.
The digoxigenin (DIG) labelling system was developed by 
Boehringer Mannheim (Germany) and is based on a steroid isolated 
from digitalis plants. Digoxigenin is linked to the C-5 position 
of uridine nucleotides via a spacer arm containing eleven carbon 
atoms.
The detection of in situ hybridisation sequences is mediated by 
avidin or anti-avidin antibodies. In fluorescence in situ 
hybridisation, the avidin or antibody may be coupled to a 
fluorochrome such as fluorescent isothyocynate (FITC) or AMCA. 
Enzymatic detection methods employing horseradish peroxidase and 
alkaline phosphatase have the added advantage that the reaction 
can be prolonged in order to amplify signals and the signals do 
not fade rapidly. Fluorescence detection provides the highest
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resolution possible with light microscopy however the signal may 
fade rapidly and thus requires rapid recording and observation 
thus the detection of single copy gene probes <2 kb is 
restricted to autoradiographic techniques. In the digoxigenin 
system, specific anti-DIG antibodies have been developed which 
bind specifically to DIG and several amplification protocols are 
available.
1.2.2 Probes
A wide variety of probes are available for use in FISH and they 
may be categorised according to the complexity of their target 
sequences. Originally, recombinant DNA libraries enriched in 
sequences from single chromosome types have been used to 
facilitate the selection of probes for molecular genetic studies 
and have also proved reliable for use in FISH.
1.2.3 Whole Chromosome Probes
Whole chromosome or chromosome-specific composite probes allow a 
specific painting of chromosomes or chromosomal regions. A 
concise and useful set of whole chromosome probes was produced 
by Gray et al.(1991). Here, inserts from complete-digest Hind 
III chromosome-specific recombinant DNA Charon 21A phage 
libraries were subcloned into Bluescribe plasmids. The phage 
libraries were produced from chromosomes of a single type 
purified by fluorescence-activated cell sorting.
1.2.4 Repeat Sequence Probes
These are probes comprising chromosome specific repetitive DNAs 
which occur in clusters mainly in centromeric or other 
heterochromatic regions such as satellite and alphoid DNAs. They 
are generally small probes which may be used when the target 
sequences are present in high copy number. They encompass a 
range of probes which specifically recognise repeat sequences at 
the centromeric region of chromosomes and are useful in the 
identification of chromosomes or chromosome copy number in 
clinical material.
1.2.5 Gene-Specific Probes
The identification of loci involved in genetic diseases has 
allowed the development of a set of probes for FISH which 
specifically recognise these regions. Initially, studies with 
such probes allowed the detection of target sequences ranging 
from 15 to 500 kilobases (kb) (Tkachuk et al.1991).
Selection of the ideal probe to be used in FISH depends on the 
size of the targeted DNA sequence, as it correlates closely with 
hybridisation efficiency. Successful hybridisation means that 
the probe should recognise both chromatids of both chromosome
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homologues on metaphase chromosomes. The efficiency by which 
probes recognise target sequences decreases with a decrease in 
probe complexity.
Cloning vectors used for the preparation of these probes include 
large insert phages, plasmids, cosmids and yeast artificial 
chromosomes (YACs). Phage vectors and plasmids contain inserts 
ranging from a few hundred base pairs up to 15 kb+ and may label 
from 50-75% of their target sites. Cosmid probes may contain 
inserts of 25-40kb and may label up to 90% of their target 
sites. They are thus important and informative, greatly reducing 
the required statistical analysis.
Most of the functional genetic units of higher organisms span 
large segments of DNA. Because of this, there arose a need to 
develop probes that could recognise regions of DNA covering many 
megabases and thus techniques were developed for isolating 
fragments of mammalian chromosomes as YACs. YACs were first used 
to isolate fragments of human DNA ranging from 100-1000 kb 
(Burke et al.1987). Techniques for the isolation and cloning of 
YACs have since been refined and have been successfully applied 
in FISH studies and may be potentially applied in long-range 
physical mapping of human chromosomes.
1.2.6 Chromosomal in situ Suppression Hybridisation
Most genomic DNA fragments of higher organisms contain 
ubiquitously occurring interspersed repetitive sequences (IRS) 
for example, Alu-elements and L-l elements. These IRS’s result 
in additional background signals throughout the genome of 
higher organisms and non-specific background noise during FISH 
reactions. Protocols have been designed to suppress the 
hybridisation signals from these repetitive sequence elements 
using competitor DNA (Lichter, et al. 1988) . Human Cot 1 DNA is 
selectively enriched in highly repetitive DNA and is used as 
competitor DNA.
1.2.7 Applications of FISH
Classical cytogenetics employs chromosomal staining techniques 
in order to identify specific chromosomal abnormalities. These 
techniques, although providing information about the whole 
genome, provides little information about abnormalities in DNA 
regions of a few kilobase pairs or less. In addition, the 
chromosomal origins of marker chromosomes may be ambiguous and 
thus complex karyotypes may not be successfully analysed. FISH 
analysis ' may be applied to both metaphase and interphase 
analysis.
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1.2.8 Metaphase Analysis
Conventional cytogenetic techniques require that cells generate 
well-spread and high quality metaphase chromosomes in order for 
a successful karyotypic analysis to be performed. The same 
applies to metaphase analysis using FISH where quality metaphase 
chromosomes are required to generate appropriate signals.
FISH analysis of metaphases has been extremely successful 
especially in the area of screening for numerical abnormalities. 
In individuals with Down’s syndrome, a whole chromosome paint 
probe of chromosome 21 may successfully detect trisomy 21 in 
cells from a patient with the syndrome. This technique has been 
even more useful in the detection of structural abnormalities 
and specific translocation events. The t(9;22) translocation in 
chronic myeloid leukaemia (CML) may be detected using dual or 
FISH with chromosomes 9 and 22 or single colour FISH using 
either chromosome 9 or 22 in patients suspected of having 
CML.Structural abnormalities such as subtle deletions and 
inversions may be difficult to detect using this approach. More 
accurate detection of the t(9;22) may be further accomplished by 
using whole chromosomal library probes specific for the BCR gene 
and ABL gene loci. The two probes are labelled with different 
fluorochromes and the BCR-ABL fusion may be detected on the 
short Ph chromosome using a dual FISH detection system. The use 
of FISH to elucidate translocation events has been used 
extensively in the field of leukaemia (Becher et al.1991; 
Spelemann et al.1991) and amplification events in human tumours 
have also been analysed successfully (Avivi et al.1992).
Lichter et al.1990 states that the location of probes along 
chromosomes may be determined to within a few megabases. Using a 
specific probe, deletions of the region targeted by the probe 
can be detected due to loss of the hybridisation domain. 
Amplification events may be detected by the increase in 
intensity, area of hybridisation domain or by counting the 
number of resolvable hybridisation sites (Tkachuk et al.1991).
The introduction of a chromosomal stain to the FISH protocol 
allows the position of certain probes to be determined and 
subsequently mapped, relative to a certain chromosomal band. The 
chromosomal counterstain 4,6 Diamidino-2-phenylindole 2HC1 
(DAPI) is stable under light excitation over a long time and its 
emission spectrum doesn’t overlap with those of other 
fluorochromes. It does not interfere with the hybridisation 
procedure as it is introduced post-hybridisation and its 
affinity for AT-rich DNA sequences confers to this dye the 
property to produce G-bands. The red counterstain propidium 
iodide alone does not produce banding but cells that have been 
exposed to bromodeoxyuridine (BRDU) may produce chromosomal 
bands on metaphase after staining with this dye.
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The use of CISS hybridisation together with digital imaging 
microscopy has allowed mapping of segments with speed and 
precision (Lichter et al.1990). Probes may be ordered along a 
chromosome by using mapping co-ordinates defined by the fraction 
of the distance between the signal and a reference point 
(usually chosen to be the end of the short arm of the chromosome 
pter) to the total length of the chromosome, that is, FLpter 
(fraction length of chromosome with fraction length pter) . The 
reliability of a FLpter map is dependent on the condensation 
state of the chromosome a greater resolution being obtained with 
elongated prometaphase chromosomes.
1.2.9 Interphase Analysis
One drawback with metaphase analysis, is the requirement for 
cells to be grown in vitro. This is time consuming, labour 
intensive and generally, growth conditions which apply to one 
specimen may have to be adjusted to suit another. With 
interphase analysis, only a few hundred representative cells are 
required for accurate results.
The concept of analysing chromosome aberrations in interphase 
nuclei started with the detection of numerical aberrations of 
the sex chromosomes by staining of the Barr and Y bodies. Since 
then, the technique has been successfully applied to the 
analysis of tumour specimens where a difficulty in producing 
metaphase chromosomes exists. Numerical abnormalities may be 
detected using chromosome-specific repeat sequence probes. These 
produce intense hybridisation signals which may easily be 
enumerated. They are especially successful in detecting 
aneuploidies of specific tumours such as gliomas, bladder, 
breast carcinomas and specific leukaemias.
In the area of bone marrow transplantation, repeat sequence 
probes for the Y chromosome have proved useful in assessing the 
success of bone marrow transplants. If a male recipient receives 
cells from a female donor, the frequency of residual male cells 
can be assessed quickly and accurately using this method. Using 
two-colour or dual FISH, interphase cells may be analysed for 
the detection of a successful transplant especially in female 
recipients of male donors using centromeric probes for X and Y 
chromosomes.
FISH with repeat sequences does not allow for the detection of 
structural abnormalities unless the target repeat sequence is 
involved. Whole chromosome probes are not as useful in 
interphase analysis as they are in metaphase analysis and 
therefore may not be applied in interphase identification of 
tumour cells where complex structural and numerical 
abnormalities are present as domain overlaps may be extreme 
(Tkachuk et al.1991).
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AIMS OF THIS STUDY
The specific aim of this study is to unravel the significance of 
chromosome lip involvement in ovarian carcinoma through analysis 
of two epithelial ovarian carcinoma cell lines, UW0V2 and 
UW0V2(Sf), which both harbour chromosome lip abnormalities in 
the region Ilpl3-pl5. Cell line UW0V2 was established in 1986 
from ascitic fluid obtained from a 52 year-old female with 
ovarian cancer. Cell line UW0V2(Sf) was established from cell 
line UW0V2 after exposure of this cell line to serum-free 
conditions (Golombick et al. 1990).
Specific goals are to:
1. Collect and prepare DNA markers specific for the region 
Ilpl3-pl5
2. Use these markers to map the breakpoint of the lip 
abnormality using the technique of Fluorescence in situ 
Hybridisation.
3. Determine the involvement of this region in fresh tumour 
samples and compare these results to that of the cell 
lines.
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SECTION 2.0
MATERIALS AND METHODS
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2.1 CELL CULTURE AND CYTOGENETIC TECHNIQUES
2.1.1 Tissue Culture of Cell Lines
Two cell lines UW0V2 and UW0V2(Sf) were obtained from Terry 
Golombick, Department of Medicine, University of the 
Witwatersrand (Golombick et al. 1990). UWOV2 was propagated in 
RPMI 1640 medium (Highveld Biological, South Africa) with 2% 
Foetal Calf Serum (FCS) (Highveld Biological, South Africa) 
while the subline UWOV2(Sf) was maintained in RPMI 1640 medium 
without any exogenous protein or serum supplementation. Cultures 
were passaged at confluence and cultures were chosen at random 
and at no particular passage for the purposes of this study.
For the supported growth and proliferation of human cell lines 
in culture, it is necessary to supplement growth media with 
serum in order to supply yet undefined factors to satisfy yet 
undefined cellular functions. The effects of serum addition are 
numerous and under serum-supplemented culture conditions it is 
often difficult to distinguish biologically between the effects 
of non-specific ’nutritional* factors of serum and those of 
specific regulatory factors (Guilbert et al. 1976). In general, 
serum supplementation provides both attachment (Elsdale et 
al.1972) and growth factors (Antoniades et al.1982).
Tissue culture of human cell lines under serum-free conditions 
eliminates the non-specific effects of serum addition and allows 
investigation into the biological expression of cells especially 
in the field of growth factors. In the case of cell line 
UW0V2(Sf), valuable information has been obtained on the 
production of growth factors and other regulatory proteins and 
their involvement in the propagation of ovarian carcinoma 
(Golombick, Johannesburg, South Africa).
2.1.2 Tissue Culture of Fresh Tumour Material
Fresh tumour material was obtained from Dr. Franco Guidozzi, 
Department of Gynaecology and Obstetrics, Johannesburg General 
Hospital. Three specimens (T2, T4, and T5) were obtained and all 
tumours were epithelial in origin.
Using a scalpel, tumours were cut up into pieces of 
approximately 2mm3 . Pieces were placed into 25cm2 flasks 
(Nunclon, Roskilde, Denmark) and then exposed to 0,3%
Collagenase A (Boehringer Mannheim, Germany) in RPMI 1640 medium
(GibcoBRL, U.S.A.) and incubated overnight at 37°C in 5% C02. The 
resulting cell suspension was gently shaken and then layered 
onto 100% Hypaque-Ficoll-1077 solution (Sigma Diagnostics, 
U.S.A.) and centrifuged at 1750rpm for 30 minutes. The upper 
phase was recovered and washed twice in Hank's Balanced Salts 
Solution (HBSS) (Highveld Biological, South Africa) at 1400rpm 
for 10 minutes each. Cells were enumerated using Trypan blue 
viability stain (Appendix A) . Cells were resuspended in RPMI
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1640 medium containing 15% Foetal Bovine Serum (FBS)(GibcoBRL, 
U.S.A.) and 5ml Penicillin G Sodium (lOmg/ml)/Streptomycin 
Sulphate (lOmg/ml)(Highveld Biological,South Africa) and then 
seeded into 25cm2 flasks at a concentration of 2xl06 cells/ml.
Cultures were incubated at 37°C in 5% C02. All centrifugation 
steps were performed in a Beckman GS-6R benchtop centrifuge.
2.1.2.1 Collection and Transport of Specimens
Collection media for the transport of tumour specimens depends 
on the medium of choice. Several groups have used RPMI 1640, 
saline or Hanks Basic Salt Solution as the main transport medium 
while other groups report that dry collection and transportation 
is as effective, however, the time between receipt of and 
processing of the specimen has to be reduced significantly. 
Specimens received at room temperature or ambient temperature in 
collection medium appear to be the most common procedure 
(Lawce, 1994) while transport on ice (4°C) allows the specimen to 
remain viable for up to 24 hours.
The specimen is usually examined either by eye or by dissecting 
microscope depending on the size of the specimen. Areas of 
differing morphology are dissected out and cultured separately 
while tissue considered as necrotic or fat may be discarded. The 
tissue may then be rinsed in medium, saline or HBBS with or 
without antibiotics.
2.1.2.2 Cell Dissociation
The two principle methods used for the dissociation of ovarian 
tumours include the mechanical dissociation method and the 
enzymatic dissociation method. Generally, the more soft, friable 
tumours are mechanically disaggregated by pressing the cells 
through sieves of gradually reduced mesh, or by forcing the 
cells through a syringe or needle.
Kusyk et al. 1979, introduced a technique which employed the 
enzyme collagenase in the disaggregation of tumour material for 
cytogenetic studies. Collagenase in a non-cytotoxic hydrolytic 
enzyme which is isolated from Clostridium hystolyticum and 
operates optimally in isotonic medium of pH range 6.5 to 7.8. It 
acts by dissolving connective tissue without damaging cell 
surface structure. Sandberg et al, 1986, observed that tumours 
treated with 200U/ml of collagenase for 16-24 hours in culture 
medium yielded a larger number of metaphases with analysable 
chromosomes (in 80% of tumours tested) than tumours treated with 
higher concentrations of collagenase (lOOOU/ml) for a shorter 
period of time.
For more resilient tumours, treatment with warm trypsin (0.25%) 
for a short period of time helps in dissociating the tissue 
prior to collagenase treatment. This method however should not 
be employed with epithelial cells as it may be damaging to them,
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while trypsin remains ineffective in dissociating more fibrous 
material and connective tissue.
The removal of contaminating red blood cells (RBCs) from 
dissociated cell cultures may be achieved by treatment with 
ammonium chloride (NH4C12) for 10 minutes at 4°C (Golombick et 
al. 1990) . This procedure eliminates RBCs but no other
contaminating stromal cells. It is particularly
effective for ascitic fluid specimens. This method however 
usually requires the specimen to undergo several treatments and
thus the risk of tumour cell 
centrifugation step.
loss is increased with each
After enzymatic dissociation, cells are usually rinsed to
decrease or remove enzymatic activity and then directly cultured 
(Lawce. 1994) . In this present study, the method of Ficoll 
separation was an innovative idea the aim of which was to obtain 
as pure a cell sample as possible without the presence of 
contaminating ’normal1 cells.
2.1.2.3 Culture Media
The most commonly used medium for the growth of ovarian tumour 
cells is RPMI 1640 medium. Other media include McCoy’s 5A, MEM 
and Changs media. All growth media contain a mixture of 
vitamins, glucose, buffered salts and amino acids. Antibiotics 
and fungicides are added to prevent bacterial and fungal 
contamination. Foetal bovine serum (FBS) is often used in 
preference to FCS as it is much richer and conducive to growth 
conditions than FCS which may be toxic to cells under incorrect 
conditions (Stewart et al. 1986).
2.1.2.4 Incubation
Incubation temperature should be maintained between 36.8°C and 
37.5°C. The gas mixture is not as important but 5% C02 in ambient 
air is common practice.
2.1.3 Cell Culture of Ascitic Fluid
Ascitic fluid from ovarian tumours was obtained from Dr. Franco 
Guidozzi, Department of Gynaecology and Obstetrics, Johannesburg 
General Hospital. Four ascitic fluid specimens were obtained 
(AF-1, AF-2, AF-3 and AF-5) . Ascitic fluids AF-2 and AF-5 were 
aspirated from patients from which tumours T2 and T5 were 
obtained.
The fluid was centrifuged at 1400rpm for 10 minutes and the 
resulting pellet was resuspended in RPMI 1640 medium. The 
suspension was layered onto 100% Hypaque-Ficoll-1077 solution 
and centrifuged at 1750rpm for 30 minutes. The upper phase was 
recovered and washed twice in Hank’s Balanced Salts Solution.
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Cells were enumerated using Trypan blue viability stain
(Appendix A) . The pellet was resuspended in RPMI 1640 medium 
containing 15% FBS and 5ml Penicillin G Sodium
(lOmg/ml)/Streptomycin Sulphate (lOmg/ml)(Highveld
Biological,South Africa) and then seeded into 25cm2 flasks at a 
concentration of 2xl06 cells/ml. Cultures were incubated at 37°C 
in 5% C02. All centrifugation steps were performed in a Beckman 
GS-6R benchtop centrifuge.
2.1.4 Metaphase Arrest
Flask cultures of UWOV2 and UWOV2(Sf) were grown until sub­
confluent while fresh tumour and ascitic fluid cultures were 
grown for 16-24 hours and then exposed to arresting solution 
(6pl/ml) (TC Arresting Solution, Difco Laboratories, U.S.A.) for 
2 hours at 37°C in 5%C02.
The main arresting agent of choice is Colcemid. Colcemid is a 
synthetic compound which prevents spindle formation arresting 
cell division at mitosis while promoting dispersion of the 
arrested metaphases. Its naturally occurring analogue colchicine 
acts in a similar way, however, prolonged exposure to this 
compound leads to marked chromosomal contraction and
condensation resulting in poorer definition of the chromosomes.
The time of mitotic arrest in non-synchronised cultures depends 
on the tumour cell cycle ( doubling time as well as on the 
concentration of arresting solution used.
2.1.5 Cell Cycle Synchrony
In order to increase the yield of metaphases obtained from cell 
line UWOV2(Sf), an attempt was made to synchronise cultures 
using methotrexate (MXT) . The method used assumes that the 
doubling time of UWOV2(Sf) cells follows that of normal human 
peripheral blood lymphocytes. Sub-confluent cultures were 
exposed to MXT (25|xg/ml) (Lederle IV 50, S.A. Cyanamid (Pty) 
Ltd., South Africa) for 17 hours at 37°C. The MXT was removed and 
cells were washed briefly in Phosphate buffered saline (PBS) 
(Appendix A).
Two releasing agents were used to investigate their efficacy in 
influencing metaphase yield. The first releasing agent used was 
thymidine. Cultures were exposed to RPMI 1640 medium containing 
thymidine (0.0048pg/ml) (Fluka BioChemika, U.K.) and incubated
for 5 hours at 37°C . Arresting solution was then added for 1 
hour. The second releasing agent used was Bromodeoxyuridine 
(BRDU) . Cultures were exposed to RPMI 1640 medium containing 
BRDU (lOpl/ml)(5mg/ml stock)(Sigma Diagnostics, U.S.A.) and 
incubated for 6 hours at 37°C. Arresting solution was then added 
for 1 hour.
page 22
Methotrexate (MXT) is a folic acid antagonist. Folic acid in its 
active form is an enzyme which is important in several cellular 
metabolic reactions as well as in the synthesis of thymidine. 
Addition of MXT to cells slows down thymidine synthesis thus 
blocking DNA replication at the G0 phase of the cell cycle. The 
subsequent addition of thymidine-rich culture medium to the 
cells allows them to complete replication and to proceed to 
mitosis in synchrony. This improves the mitotic index and the 
quality of direct harvests.
The use of BRDU as a releasing agent has several benefits. BRDU, 
a thymidine analogue, induces chromosomal elongation and 
improves definition of chromosomal bands (Yunis, 1976) binding 
preferentially to G-C-rich areas. However, cultures treated with 
BRDU may not be G-T-G banded as the heterochromatin structure is 
drastically altered and thus the banding method of choice would 
be the R-banding (reverse banding) technique. Release time for 
tumour cultures differ according to the type of tumour and its 
cell cycle.
2.1.6 Culture of Human Peripheral Blood Lymphocytes
Cultures of human peripheral blood lymphocytes were established 
as a source of control material for Fluorescence in situ 
Hybridisation (FISH) studies.
Fresh blood was collected from volunteer subjects. 0.5ml of 
blood was seeded into 8.5ml of RPMI 1640 medium supplemented 
with 15% FCS and antibiotics (as described in section 1.2). 
Cultures were incubated at 37°C in 5% C02 for 43 hours. MXT 
(25|ig/ml) was added to the cultures and cells were incubated for 
17 hours at 37°C in 5% C02. Cultures were centrifuged at 1400rpm
for 10 minutes at room T° to remove the MXT. The pellet was 
resuspended in fully supplemented RPMI 1640 medium containing
thymidine (0.0048pg/ml) and cultures were incubated for 5h hours 
at 37°C in 5% C02. Arresting solution (6jxl/ml) was added and the 
cultures were incubated for half an hour at 37°C in 5% C02.
All centrifugation steps took place in a Beckman GS-6R benchtop 
centrifuge.
2.1.7 Harvesting of Cell Cultures
After metaphase arrest, the supernatant was removed from flask 
cultures and cells were exposed to 0.25% trypsin in PBS (Difco 
Laboratories, U.S.A.) for 5-15 minutes or until cells lifted off 
the flask. More strongly adherent cells were mechanically 
dislodged by gently hitting the side of the flask. Cells were 
resuspended in Hank's Balanced Salts Solution and washed once by 
centrifugation at room T°.
page 23
Human peripheral blood lymphocyte cultures were removed from 
incubation and centrifuged at 1400rpm for 10 minutes.
The pellets from flask and blood lymphocyte cultures were 
resuspended in 10ml of 0.75M KC1 and incubated for 20 minutes 
for cell lysis to occur. The KC1 was removed by centrifugation 
at room T° and cells were fixed by the addition of 10ml of ice- 
cold methanol/acetic acid fixative (3:1) and washed by 
centrifugation at 4°C. The resulting pellet was resuspended in
ice-cold fixative and incubated at -20°C in preparation for 
slidemaking. All centrifugation steps were at 1400rpm for 10 
minutes in a Beckman GS-6R benchtop centrifuge.
In situ harvests are accomplished with hypotonic solutions of 
various concentrations of sodium citrate, KC1, NaCl or cancer 
hypotonic solution (CHS - a mixture of KC1, EGTA and Hepes 
buffer)(Lawce, 1994). The effect of the hypotonic solution acts 
synergistically with the colchicine in swelling the cells and 
dispersing the metaphase chromosomes.
Fixative is added to the hypotonic solution briefly to stop its 
action. The methanol:acetic acid fixative is made up fresh just 
before use and several successive fixative washes effectively 
removes any remaining debris. By washing several times, the 
adherence of cells to glass slides as well as their staining 
efficiency is greatly enhanced. Methanol, being highly volatile, 
aids in the flattening and dispersion of chromosomes while the 
chromosomal structure remains unaffected by the presence of 
acetic acid.
2.1.8 Slide making
Cells stored at -20°C were washed for a minimum of five times in 
ice-cold fixative by centrifugation at 1400rpm for 10 minutes at
4°C. The pellet was resuspended in a small volume of fixative and 
stored on ice. Microscope slides, cleaned overnight in 100% 
ethanol, were dried and stored in a dry dust-free place. Slides 
were flooded with ice-cold fixative and 15|al of cell suspension 
was dropped onto the slide from a height of ±20cm. The slide was 
steamed briefly (4-6 seconds) and then placed flat in a humid 
chamber (±45% humidity) to dry for 5 minutes followed by air 
drying for 5 minutes.
The slides were dehydrated in an ethanol series, 5 minutes each 
of 70%,90% and 100% ethanol. Slides for banding were stored at
room T° for 7 days and slides to be used in Fluorescence in situ 
Hybridisation (FISH) were sealed in a slideholder containing
silica gel and stored at -20°C until needed.
Methods of slidemaking vary between different tumour specimens. 
Flooding the slide with ice-cold fixative, dropping the specimen
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from a height of approximately 20cm and steaming proved to be 
the best method for chromosome spreading in this study.
2.1.9 Giemsa Banding Technique using Trypsin (GTG Banding)
Slides were exposed to 0.005% trypsin (Difco Laboratories,U.S.A) 
in PBS. The duration of exposure to trypsin varied depending on 
slide age, slide condition, atmospheric conditions and enzyme 
activity and thus exposure time varied between banding sessions 
but was carefully standardised for each individual session. 
Generally, 7-day old slides were exposed to trypsin for ±20 
seconds. The trypsin was inactivated in 8% FCS in PBS, washed 
briefly in PBS and stained with 6% giemsa (BDH Laboratory 
Supplies,U.K.) in 6.8 buffer (Appendix A) for 2% minutes. Slides 
were rinsed in distilled water and air-dried.
Slides were viewed by brightfield microscopy using an Olympus 
BH2-RFCA microscope and cells were photographed using AGFA 
Agfapan APX 100 film.
Prior to banding, slides are enzymatically treated with trypsin, 
a proteolytic enzyme which enhances the basic chromosome 
structure of the metaphases. Giemsa stain, a methylene blue- 
eosin based stain, is a complex mixture of dyes containing the 
main ingredient thiazin. The mechanism of band formation is not 
fully understood, but it is thought that the thiazin molecules 
"stack" alongside the DNA only in AT-rich areas. The thiazin 
then binds to eosin forming a magenta complex. The resulting 
banding pattern on chromosomes is due to the chromatin in these 
bands interacting ionically with the thiazin dyes by means of 
hydrophobic bonding forces. This results in each chromosome 
having its own unique banding pattern. This is only a proposal 
for the action of Giemsa in chromosome staining and several 
other theories have been proposed (Comings, 1975; Sumner, 1980; 
van Duijn et al. 1985).
2.2 PLASMID PROBES
2.2.1 COLLECTION OF PLASMID PROBES
2.2.1.1 Chromosomally Enriched Plasmid Probes
Chromosomally enriched plasmid library probes, originally
obtained by our laboratory, were received from Joe Gray, San 
Fransisco, U.S.A. in the form of MAX Efficiency DH5a transformed 
E.coli cells with ampicillin resistance (Gray et al.1991). Cells 
were stored in 60% glycerol at -70°C.
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2.2.1.2 Centromeric Alphoid Repeat Probes
Centromeric alphoid repeat probes, originally obtained by our 
laboratory, were received from Frank Spelemann, Belgium, in the 
form of MAX Efficiency DH5a E.coli competent cells. Centromeric 
probe 3 was represented by an insert size of 2.1 kilobases (kb) 
in the vector pSP65. Centromeric probe 11 was represented by an 
insert size of 0.85 kb in the vector pSP64. Both probes were 
ampicillin resistant. Cells were stored in 60% glycerol at -70°C.
2.2.1.3 Single Copy Gene Probes
The human globin P gene probe, mapping to the region llpl5.5 on 
chromosome 11, was obtained from Corne Strydom, Department of 
Medical Biochemistry, Wits Medical School, in the form of 
transformed bacterial cells. This probe was represented by an 
insert size of 7.4 kb in the vector pSPP and this probe was used 
in FISH studies.
The probe IGF-II representing the human insulin growth factor II 
gene mapping to the region llpl5.5, had been obtained from 
Melissa Little, Edinburgh, Scotland, (Schneid et al.1989). This 
probe was represented by an insert size of 660 base pairs (bp) 
in the vector pGEM4 and was used in slot blot assays for gene 
dosage studies.
2.2.2 PLASMID PROBE PREPARATION
2.2.2.1 Bacterial Transformation
MAX Efficiency and SE Efficiency DH5a E.coli cells were used in 
this procedure. The DH5a cells, stored at -70°C, were thawed on 
ice and dispensed into 50 \il aliquots. Aliquots not used were 
freeze-dried using 100% ethanol and dry ice and stored at -70°C.
60ng of plasmid DNA from the probe IGF-II was added to a 50|il 
cell suspension and left on ice for 30 minutes. Cells were heat
shocked for 20 seconds at 37°C and then left on ice for 2 
minutes. The cells were then inoculated into 500^1 of Luria- 
Bertani (LB) broth (Appendix B) without antibiotics and shaken 
for 60 minutes at 37°C. Agar plates (Appendix B) containing 
50ng/ml ampicillin (lOOmg/ml stock solution) were inoculated 
with 50jil and 450|al of broth respectively and incubated 
overnight at 37°C. These plates were subsequently used as a 
source of inoculation for liquid cultures.
The ability to transfer plasmids into bacterial cells has become 
an integral part of molecular biology. The protocol described 
above is based on the observation that E. coli cells and DNA 
productively interact in an environment of divalent cations at 
low temperatures. The divalent cations referred to is a solution
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of CaCl2 which effectively renders the bacterial cells competent, 
that is, enables them to take up high molecular weight double- 
stranded intact DNA. Competence varies with the physiological 
state of the cells and is highest at the middle phase of 
exponential growth, rapidly declining to a minimum later on. The 
way in which CaCl2 influences bacterial transformation is not 
fully understood. Two hypotheses are that:
(a) CaCl2 causes DNA to precipitate onto the outside of 
bacterial cells
(b) the cationic solution induces some kind of change in 
cell wall properties that improves DNA binding
Actual uptake of DNA into competent cells is achieved by briefly 
raising the temperature in a process known as fheat shock'. The 
optimal times of heat shock are partly a function of the surface 
to volume ratio of the cell suspension and the thermal 
conductivity of the tubes used.
The above protocol is simple but relatively inefficient where 
transformation efficiency is concerned. In order to achieve 
maximum transformation efficiency, several additional steps may 
be employed including (i) the addition of monovalent cations to 
the transformation buffer (ii) treatment of cells with solvents 
and sulphydryl reagents and (iii) growth of cells in medium 
containing elevated levels of magnesium (10-20mM).
2.2.2.2 Plate Inoculation and Plasmid DNA Amplification
The chromosomally enriched plasmid probes specifically chosen 
for the purpose of elucidating the chromosomal origin of the 
chromosome llp+ abnormality were those which represented 
chromosomes commonly involved in abnormalities found in ovarian 
carcinomas. These corresponded to human chromosomes 1, 3, 5, 6, 
7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 19, 21, 22, X.
The centromeric alphoid repeat probes chosen for the purpose of 
this study were specific for human chromosomes 3, 8 and 11.
Bacterial cells were streaked onto agar plates containing 
ampicillin 50|ig/ml (stock: lOOmg/ml) and grown overnight at 37°C. 
Colonies were inoculated into liquid culture consisting of 250ml
LB with ampicillin (50pl/100ml) (stock:lOOmg/ml) and grown
overnight at 37°C on an orbital shaker until bacterial growth had 
reached log phase. For chromosomally enriched plasmid probes and 
centromeric probes, a minimum of six streak plates were used to 
inoculate liquid cultures while for single copy gene probes, a 
single colony was chosen for inoculation.
For the preparation of chromosomally enriched plasmid libraries, 
colonies on plates were pooled so as to give a better 
representation of fragments from the chromosome under study. In
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the case of single copy gene probes, a single colony was chosen 
so as to avoid selection for ampicillin-resistant mutations.
2.2.2.3 Plasmid Extraction
Bacterial cells were pelleted at 5000rpm for 15 minutes at 4°C. 
Cells were resuspended in lysosyme solution containing 2mg/ml 
lysosyme (Boehringer Mannheim, Germany) in Lysosyme Buffer (25mM 
Tris-Hcl pH 7.5, lOmM EDTA, 15% sucrose) and placed on ice for 
20 minutes. To this, 12ml of 0.2M NaOH, 1% SDS was added. Cells 
were mixed by inversion and placed on ice for 10 minutes. 7.5 ml 
of sodium acetate pH 4.6 was added. Cells were mixed by 
inversion and placed on ice for 10 minutes. Cells were
centrifuged at 15000rpm for 15 minutes at 4°C. The supernatant 
was filtered through a nylon filter and transferred to a clean 
tube. An equal volume of ice-cold isopropanol was added and the 
mixture was centrifuged immediately at 12000rpm for 15 minutes. 
The pellet was lyophylised and resuspended in 2ml of TE (Tris- 
HCl,EDTA pH 7.6). All centrifugation steps took place in a 
Beckman Model J2-21 centrifuge. Each sample was made up to 4ml 
by the addition of 2ml of TE pH 7.6. To each sample, 4g of
Cesium Chloride (CsCl) and 320 i^l of ethidium bromide 
(stock: lOmg/ml in H20) was added. Samples were mixed, placed into 
ultracentrifuge tubes and centrifuged in a Beckman
Ultracentrifuge at 45000rpm for 18-24 hours at 4°C. The plasmid 
DNA band was collected and washed 4 times with an equal volume 
of isoamylalcohol to remove the ethidium bromide. The sample was
then dyalised in TE pH 7.6 for half an hour and stored at -20°C.
The procedure described above is based on the alkaline lysis 
procedure of Maniatis et al, 1989
Lysosyme is an acid muramidase enzyme which attacks glycosidic 
bonds in the murein structure of bacterial cell walls. Its 
activity is enhanced and modulated by the lysosyme buffer which 
provides a hypotonic environment for the cells. The chelating 
agent EDTA enhances lysosyme activity while the sucrose prevents 
cells from lysing immediately and allows the production of 
osmotically fragile protoplasts.
Addition of the ionic detergent SDS results in cell lysis while 
NaOH raises the pH to 12.0-12.5 effectively denaturing non- 
supercoiled bacterial DNA while supercoiled plasmid DNA remains 
intact. The addition of sodium acetate allows denatured strands 
to reaggregate into a tangled mass which is insoluble and 
precipitates out during centrifugation. This yields a clear 
lysate consisting almost entirely of plasmid DNA. During this 
step, the action of SDS and sodium acetate renders proteins and 
RNA insoluble facilitating their removal by centrifugation.
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Cesium chloride gradient centrifugation is based on the 
observation that cesium and chloride ions are forced towards the 
bottom of a tube on centrifugation of such solutions at high 
speeds. The downward ionic migration is counterbalanced by 
diffusion creating a concentration gradient. DNA centrifuged in 
such a solution will form bands at distinct points in the 
gradient depending on its buoyant density. DNA will migrate to a 
point equal to a buoyant density of 1.7g/cm3 while RNA having a 
higher buoyant density will sediment at the bottom of the tube.
The incorporation of ethidium bromide allows differentiation of 
supercoiled DNA from linear DNA. Ethidium bromide binds to DNA 
molecules of linear DNA intercalating between base pairs causing 
partial unwinding of the double helix. This leads to a decreased 
buoyant density. Bacterial chromosomal DNA, being supercoiled 
does not unwind as easily and therefore the ethidium bromide 
cannot bind as effectively resulting in an even decreased 
buoyant density compared to that of plasmid or linear DNA. The 
result is that the two types of DNA will sediment at different 
rates. Using ultraviolet light, the relative positions of the 
bands can be seen and a pure plasmid DNA preparation can be 
extracted.
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2.3 YEAST ARTIFICIAL CHROMOSOME (YAC) PROBES
2.3.1 COLLECTION OF YAC PROBES
Twelve YAC probes mapping to the region llpl4.3-15.5 were 
obtained from Denis LePaslier (CEPH - Centre d 1Etude du 
Polymorphisme Humain,France) libraries. The gene assignments of 
the YACs can be seen in table I
I YAC
*Human Genome Mapping Locus Assignment
892g9 D11S922
785e5 D11S1318, D11S1323, D11S1338
847al2 D11S1323, D11S1338
954f 4 D11S909, D11S932
1 933b8 D11S1329, D11S1346, D11S2069
| 928dl D11S1315, D11S1346, D11S2069
922el D11S1315, D11S926, D11S1334, D11S1348, 
D11S1349
879bl0 D11S1315, D11S1334
770c6 D11S861, D11S1307, D11S926
966e8 D11S902, D11S921
845a3 D11S899, D11S1308
855bl D11S1308
Table I: The Human Genome Mapping regional assignments of CEPH 
YAC probes to the chromosomal region llpl5.5-14.3
* van Heyningen et al. 1995
2.3.1.1 YAC Amplification and DNA Extraction
YAC cultures were inoculated into 3ml of AHC medium (Appendix B)
and grown overnight at 30°C on an orbital shaker (±150rpm) . 
Glycerol stocks were made, by addition to 2ml of culture and of 
20% glycerol. Cell stocks were stored at -70°C.
The remaining 1ml of culture was inoculated into 250ml of AHC 
medium and grown for 36 hours at 30°C (150rpm) or until the
medium turned pink. This indicates that the yeast cells have 
reached log phase of growth. Cultures were then centrifuged and 
the resulting cell pellet was weighed to ensure that
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approximately lg dry weight of yeast cells was obtained per 
sample.
Cells were harvested by washing twice with 10ml of 40mM 
EDTA/90mM (3-mercaptoethanol by centrifugation at 3000rpm for 10 
minutes. The cells were resuspended in 2ml of SCE (1M sorbitol, 
0.0 6M EDTA, 0.1M sodium citrate pH 7.0) containing 1:125
dilution of p-mercaptoethanol and 5pl of lyticase (Boehringer 
Mannheim,Germany) . After incubation at 37°C for 2 hours, the 
spheroplasts were centrifuged at 3000rpm for 10 minutes and 
resuspended in 0.7ml of 50mM Tris(pH 7.4), 25mM EDTA, 500mM
NaCl, 3mM 2-mercaptoethanol, 1% SDS. Cells were incubated at 65°C 
for 15 minutes, vortexing intermittently.
A phenol/chloroform extraction was performed on each sample by 
the addition of ^volume of phenol and ^volume of chloroform 
(chloroform:isoamylalcohol 24:1). Samples were centrifuged at 
3000rpm for 15 minutes between each extraction. The final wash 
consisted of an equal volume of chloroform.
An equal volume of isopropanol was added to the aqueous phase 
and incubated at room T° for 15 minutes. The sample was 
microfuged for 15 minutes at room T° and the pellet rinsed in 
200pl of cold 70% ethanol and air dried.
The pellet was resuspended in TE (pH 7.6) and 2 units of DNAse- 
free-RNAse (Boehringer Mannheim, Germany) was added. After a 2 
hour incubation at 37°C with intermittent agitation, the DNA was 
precipitated with isopropanol as described above.
The pellet was resuspended in 0.3ml TE (pH 7.6) and the DNA was 
precipitated by the addition of 2H volumes of ice-cold 100% 
ethanol. Samples were placed at -70°C for 15 minutes and then 
microfuged at room T° for 15 minutes. The pellet was rinsed with 
cold 70% ethanol and air dried. The pellet was resuspended in TE 
pH 7.6 and stored at 4°C. All centrifugation steps took place in 
a Beckman GS-6R benchtop centrifuge and a Heraeus Biofuge 15 
microfuge.
The procedure described above is based on the method from Cold 
Spring Harbour (Dr.Turc Carel, Nice, France)
For the preparation of Yeast Artificial Chromosomes for use in 
in situ hybridisation, several protocols are available. The 
standard technique for YAC DNA isolation involves the agarose 
plug method in which yeast cells are embedded in agarose in 
order to maintain the integrity of the yeast chromosomes. The 
spheroplasting and lysing steps are performed within these 
agarose plugs and the desired YAC clones are analysed and 
isolated by Pulsed-Field Gel Electrophoresis. Using this method, 
DNA may also be labelled within the agarose plug and the agarose
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is subsequently removed during the DNA purification stage by 
elution through Sephadex G50 spun columns. This method is labour 
intensive and time consuming and the DNA yield is relatively low 
usually providing enough DNA for only three labelling reactions 
(Selleri et al.1991).
Yeasts exhibit a relatively high rate of mitotic recombination 
and because of this, artefactual clones arise due to 
intrafragment rearrangement or interfragment chimaera formation 
(Oliver et al. 1994) which may also be influenced by long 
incubation and preparation protocols and by exposure to toxic 
chemicals employed during the transformation procedures.
The method described in this present study is rapid, providing 
high quality total genomic yeast liquid DNA and therefore, the 
probability of mitotic recombination events is greatly reduced.
The most commonly used media for the growth of YACs are YEP-D, 
synthetic complete medium (such as AHC) and the dropout mix 
(which is enriched with amino acids and is used mainly for 
growth of the auxotrophic strains). The yeast strain of interest 
is grown in the desired medium to the desired density. The 
density should exceed lg dry weight of yeast cells as cell loss 
is encountered during the numerous preparation procedures. 
Inoculation of cultures should be carried out under sterile 
conditions as no antibiotics nor fungicides may be added to the 
culture medium.
In order to obtain a pure yeast chromosomal DNA preparation, the 
spheroplasting step has to be carefully defined for each 
individual strain. As a pre-treatment to spheroplasting, slowly 
growing log phase yeast strains are exposed to EDTA and p- 
mercaptoethanol which conditions the cells for spheroplasting 
and assures reproducibly rapid spheroplast formation. This is 
important as direct exposure of cells to the SCE solution may 
cause the cells to lyse too quickly. The SCE medium provides an 
osmotically stable environment for the spheroplasts preventing 
cell lysis. It is important that incubation during the 
spheroplasting stage is carried out without agitation.
Several enzymes may be used for spheroplasting. These include 
Glusulase, Oxalyticase, Zymolyase and Lyticase. Lyticase is 
secreted by Arthrobacter luteus and may yield a clearer lysate 
than other enzymes (Scott et al.1980). The rate of cell lysis is 
dependent on several factors the most important ones being the 
strain of yeast and the concentration of lytic enzyme. 
Generally, the slower growing yeast strains require more enzyme 
and longer incubation periods compared to log phase or rapidly 
growing strains. Cell lysis is accomplished by incubation in low 
salt solutions and low concentrations of SDS.
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2.4 ESTIMATION OF DNA YIELDS
In order to quantitate the yield of DNA from both plasmid and 
YAC preparations, two methods were employed to ensure that an 
accurate estimation was obtained. This was done to ensure that 
the correct amount of DNA was employed which would influence 
further steps leading to the use of this DNA in Fluorescence in 
situ Hybridisation.
2.4.1 Agarose Gel Electrophoresis
A 1% agarose gel was prepared in lxTAE Buffer (Appendix A) 
containing 3|il/100ml ethidium bromide (stock: lOmg/ml in H20) .
After 5jil of each sample was mixed with ljxl of loading dye, they 
were loaded into wells and electrophoresed for 1 hour at 80V 
(±120mA) . Lambda DNA (250ng/jil) (Boehringer Mannheim, Germany), 
at various known concentrations was electrophoresed alongside 
the samples. After electrophoresis, the gel was visualised under 
UV transillumination and photographed.
2.4.2 Spectrophotometry
DNA yield was also determined spectrophotometrically using a 
Beckman Module-65 Spectrophotometer. Readings were taken at 
260nm and 280nm respectively and the concentration of plasmid 
DNA was determined by using the formula:
DNA yield (|ag/|LL) = spec, reading x O.D. x dilution factor
1000
O.D. = Optical Density where 1 O.D.= 50 for DNA at 260nm
For the most accurate results, the two methods of DNA 
quantification described above should both be employed. Using 
spectrophotometry, readings should be taken at 260nm and 280nm 
in the ultraviolet range of the spectrum. At 2 60nm, the amount 
of double-stranded DNA may be determined where an O.D. of 1 is 
equal to approximately 50jig/ml. The purity of a DNA sample may 
be determined by calculating the ratio between readings at 260nm 
and 280nm, that is O.D.26o/O.D.28o (this reading should be in the 
range of 1.8-2.0). The drawback with this method of 
quantification is that concentrations of DNA lower than 250ng/ml 
cannot be detected accurately (Maniatis et al.1989)
Agarose gel electrophoresis incorporating ethidium bromide is a 
more sensitive quantitative method. The strength of the 
fluorescence of ethidium bromide under ultraviolet light allows 
DNA samples to be compared with that of a series of standards. 
As little as l-5ng of DNA may be detected using this method.
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2.5 PROBE LABELLING
Before labelling, plasmid DNA was treated with DNAse-free-RNAse 
(Boehringer Mannheim, Germany) (lOjil/lOOjil) for 1 hour at 37°C. The 
DNA was then precipitated by the addition of l/2ovol of sodium 
acetate pH4.6 and 2^vol ice-cold ethanol. The sample was then
microfuged for 15 minutes at 4°C and the pellet rinsed with cold 
70% ethanol and air-dried. The pellet was resuspended in lOOjil 
of TE (pH7.6).
Plasmid and YAC DNA was labelled with either biotin-16-dUTP or 
digoxigenin-ll-ddUTP (Boehringer Mannheim,Germany) by nick
translation. For each reaction, 2[xg of template DNA per 100|il of 
reaction mixture was used and the labelling reaction was carried 
out as follows:
Reaction Mixture:
2[xg template DNA
10|il lOx nick translation buffer (0.5M Tris-HCl pH8.0, 50mM
MgCl2, 0.5 mg/ml bovine serum albumin)
10(il 0.1M p-mercaptoethanol
10|j.l lOx nucleotide stock*
0,5{il DNAse I (1:1000 in distilled water) (stock: 3mg/ml
in 0.5ml 0.3M NaCl+ 0.5ml glycerol) 
lpil DNA polymerase
The reaction mix was made up to lOOjil with ddH20
* Biotin/nucleotide stock 
dCTP 0.5mM
dGTP 0.5mM
dATP 0.5mM
dTTP 0.ImM
biotin-16-dUTP 0.4mM
* Digoxigenin/nucleotide stock
dCTP
dGTP
dATP
dTTP
digoxigenin-11
0.5mM 
0.5mM 
0.5mM 
0.375mM 
ddUTP 0.125mM
The reaction was incubated in a water bath at 15°C for 2 hours. A 
l\il aliquot was then denatured by boiling for 3 minutes, cooled 
on ice for 3 minutes and then loaded into wells of a 2% agarose 
gel prepared in lxTAE (Appendix A) with 3jil/ 100ml ethidium 
bromide (stock: lOmg/ml in H20). DNA molecular weight marker VI 
(Boehringer Mannheim,Germany) was electrophoresed alongside the 
samples. The samples were electrophoresed at 100V (±140mA) for 
half an hour. The gel was visualised under UV transillumination 
and photographed.
page 34
Fragment sizes of between 200 and 500 nucleotides were 
considered suitable for use in Fluorescence in situ 
Hybridisation.
The labelling reaction was stopped by the addition of l/i0 volume 
of stop mix (0.1M EDTA pH8.0, 1% SDS) and heated at 68°C for 15 
minutes on a heating block and then stored at 4°C.
The procedure described above is a modification of the method 
described by Langer et al. 1981.
Nick translation of DNA is based on the action of Eschericia 
coli DNA polymerase I. This enzyme adds nucleotide residues to 
the 3* hydroxyl terminus on a strand of DNA 1 nicked' by the
enzyme DNAse I. It also possesses 5' -»3' exonucleolytic activity 
and thus simultaneously removes nucleotides from the 5' end and 
adds nucleotides to the 3' end. This facilitates movement of the 
'nick' along the DNA (Kelly et al. 1970) .
The rate at which nucleotides are incorporated depends on the 
activity of DNAse I and the type of DNA template used (Maniatis 
et al. 1989) . By carrying out the labelling reaction at lower 
temperatures (±15°C), the activity of DNAse is reduced which 
prevents the degradation of DNA when extended labelling periods 
are required. This allows more efficient incorporation of the 
labelled nucleotides (Koch et al.1986). In order to optimise the 
concentrations of DNAse for labelling, varying concentrations of 
DNAse may be added to DNA samples keeping all other parameters 
constant.
Nick translation buffer is important for maintaining an optimal 
physiological environment in which the enzyme can function. 
Alterations in the pH of the buffer or ionic strength (provided 
by MgCl2) could decrease enzyme activity.
Termination of the labelling reaction is achieved by the 
addition of EDTA. EDTA inactivates enzymes indirectly by binding 
to Mg2+ ions. Short incubation at 65°C is sufficient to heat 
inactivate the enzyme.
2.5.1 Purification of Labelled DNA
Labelled DNA was purified by centrifugation through Sephadex G- 
50 spin columns in order to remove the unincorporated 
nucleotides.
The stamp was removed from 1ml syringes and a plug of silanized 
glass wool was packed at the bottom of the syringe to a height 
of 2-3mm. The column was packed with buffered Sephadex G-50 
resin (Sephadex G-50 dispersed in column buffer: lOmM Tris-HCl
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pH8.0, ImM EDTA, 0,1% SDS and autoclaved) to the 1ml mark. The 
column was centrifuged at 3000rpm for 5 minutes until the resin 
packed to the 1ml mark. The column was washed three times with 
10 Ojj.1 of column buffer by centrifugation at 3000rpm for 5 
minutes.
An eppendorf tube was then placed under the syringe and the 
labelled DNA was loaded onto the column and spun at 3000rpm for 
5 minutes. The eluted DNA sample was removed and stored at -20°C. 
All centrifugation steps took place in a Beckman GS-6R benchtop 
centrifuge.
The procedure described above is based on the method of 
Lichter,P; Cremer, T. 1991)
This method of gel filtration chromotography is used to separate 
high molecular weight DNA from smaller molecules as well as 
separating unincorporated labelled dNTP's from DNA labelled by 
nick translation. Sephadex G50 is a commonly used gel matrix, 
the porosity of which is suitable for purifying DNA larger than 
80 nucleotides in length. Smaller fragments of DNA and 
unincorporated nucleotides are retained in the pores of the gel 
(Maniatis et al.1989). The incorporation of SDS into the column 
buffer is necessary because the biotinylated probe might stick 
in the column due to hydrophobic biotin groups (Lichter, P.; 
Cremer, T. 1991).
2.6 FLUORESCENCE * IN SITU* HYBRIDISATION (FISH)
All labelled plasmid and YAC DNA probes, were tested with FISH. 
Before labelled probes were hybridized onto test slides, they 
were hybridized onto control slides of human peripheral blood 
lymphocyte metaphase cells in order to test for non-specific 
hybridisation and also probe preparation and labelling quality.
Test slides used for the purposes of this study included 
cultures from cell lines UWOV2, UWOV2(Sf), fresh tumour sample 
T5 and ascitic fluid culture AF-5.
The method described below is a modification of the method of 
Lichter, Heidelberg, Germany.
2.6.1 Slide Preparation
Slides stored at -20°C were thawed for 30 minutes at 4°C followed 
by 30 minutes at room T° before being used for FISH.
The slides were treated with lOOjal of DNAse-free-RNAse 
(Boehringer Mannheim, Germany) (2Opil/8Opil 2xSSC) per slide, for 30 
minutes at 37°C, followed by three washes of 5 minutes each in
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2xSSC (Appendix A). Slides were dehydrated in an ethanol series,
5 minutes each of 70%, 90% and 100% ethanol.
Slides were then exposed to pepsin (Boehringer 
Mannheim, Germany) (50|j.l/100ml in 0.01N HC1) (pepsin stock: 10%)
for between 10 and 15 minutes at 37°C depending on the age of the 
slide. Slides were rinsed briefly in PBS and then washed for 5 
minutes with lxPBS, 50mM MgCl2 in distilled water followed by a 5 
minute wash with lxPBS, 50mM MgCl2, 4% paraformaldehyde (Appendix 
A) in distilled water.
Slides were washed for 5 minutes in lxPBS and then dehydrated in 
an ethanol series 5 minutes each of 70%, 90% and 100% ethanol.
Slides were stored at 60°C in preparation for slide denaturation. 
Slides were denatured in denaturation solution:
5ml 20xSSC
5ml 0.5M phosphate buffer (Appendix A)
5ml distilled water 
35ml deionized formamide
Denaturation of the slides was at 70°C for exactly 2 minutes, the 
timing of which was critical. This was followed by immediate 
dehydration in an ice-cold ethanol series 5 minutes each of 70%, 
90% and 100% ethanol.
The pre-treatment of metaphase slides with RNAse serves to 
remove any endogenous RNA that may be present in the 
preparation. This step however is not critical and might even 
negatively influence the quality of results obtained (Lawrence 
et al.1988). The precise action of HC1 on chromosomal structure 
is not known but it may aid in the extraction of proteins and in 
the hydrolysis of target sequences which effectively increases 
the signal to noise ratio. For the effective penetration of 
probe molecules, cells are mildly digested with pepsin. The 
concentrations of pepsin are adjusted according to the source of 
the material, age of slide and purity of the metaphase cells 
(Lichter, Heidelberg, Germany) . Proteinase K may be used in 
place of pepsin. Pinkel et al. 198 6, stated that for optimal 
digestion, the concentration of proteinase K is adjusted so that 
almost no phase contrast microscopic image remains on a dry 
slide.
During the paraformaldehyde washing step, cells are fixed in 
situ which maintains the morphology of the target sequences. 
This step is important especially if several pre-treatment steps 
are employed which risks altering chromosome morphology.
For the successful slide denaturation, it is important that all 
parameters are carefully defined. DNA denatures in 0.1-0.2M Na+ 
at 90°C-100°C. The addition of an organic solvent such as
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formamide, reduces the thermal stability of double-stranded DNA 
allowing separation of the double helix at lower temperatures. 
This reduction in the melting temperature of DNA occurs in a 
linear fashion with a 0.72°C reduction for every % of formamide. 
Such a procedure for denaturation requires a shorter time which 
has a less adverse effect on chromosome morphology which may be 
altered at higher temperatures.
2.6.2 Probe Preparation
For each FISH reaction, the amount of labelled probe used, 
varied with the kind of probe. In a 12|il volume of final 
hybridisation mixture, 2-2Ong of centromeric probe DNA or 80- 
120ng of cDNA (with insert size >2kb) was used. For
chromosomally enriched plasmid probes, 150-500ng of labelled DNA 
was used while for YAC probes, 500ng-ljig of labelled DNA was 
used for each FISH reaction.
The method of chromosomal in situ suppression (CISS) 
hybridisation was used for chromosomally enriched plasmid 
probes, total genomic single copy gene probes and YAC probes. 
This method involves the addition of competitor DNA to the probe 
during the probe preparation step, the function of which is to 
suppress the hybridisation signal from ubiquitous repeated 
sequences such as Alu and Kpn elements (Lichter et al. 1990).
Probes were precipitated using the following mix:
competitor DNA *
ljil salmon testes DNA (Sigma Diagnostics, U.S.A.)
I / 2 0 V 0 I  sodium acetate pH4.6
2^vol ice-cold ethanol
* Human cot 1 DNA (GibcoBRL,U.S.A.)
For YAC probes, 3ug/50ng of labelled probe was used
For single copy probes, 60ng/50ng of labelled probe was used
The mixtures were incubated at -70°C for 15 minutes and then 
microfuged for 15 minutes at 4°C. The pellet was washed with cold 
70% ethanol by microfuging for 5 minutes at 4°C and then air- 
dried. The pellet was resuspended in 6|il of deionized formamide 
and shaken on a vortex for ±30 minutes. To this, 6jil of dextran 
sulphate (20% in 4xSSC) was added and the probe was dissolved at
37°C for 30 minutes.
The probe DNA were denatured on a hotplate at 76°C for 5 minutes 
and then pre-annealed for 15 minutes at 37°C and then immediately 
placed on ice.
During probe preparation, lyophilised probes are initially 
dissolved in deionized formamide because DNA that has been
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modified with either biotin or digoxigenin, introduces 
hydrophobic residues to the DNA which dissolve more easily in 
formamide than in aqueous solutions (Lichter, P.; Cremer, T. 
1991b).
2.6.3 Hybridisation
The denatured probe mixture was added to the denatured slides. 
(Often, especially in the case of dual or two-colour FISH, 
several probes were combined together at this stage and 
hybridized onto a single slide. In such cases, however, the 
volumes of the hybridization mix for each individual probe was 
adjusted so that the final volume of the combined hybridisation
mixture did not exceed 16|il) .
A coverslip was placed over the hybridisation area and the edges 
of the coverslip were sealed with rubber cement and allowed to 
dry on a hotplate at 37°C for a few minutes. Slides were then 
placed in a moist chamber overnight at 37°C. (In some cases, the 
hybridisation was left for up to 48 hours which improved the 
binding efficiency).
After hybridisation, coverslips were removed and the slides were
washed in 50% formamide/2xSSC for 10 minutes at 42°C followed by 
three washes each of 5 minutes in 50% formamide/2xSSC. Slides 
were then washed three times each of 5 minutes in lxSSC (kept at
60°C) at 42°C.
Several parameters affect the hybridisation kinetics of in situ 
hybridisation. Generally, DNA renatures at about Tm -25°C and is 
fairly independent of pH in the range pH5-9. Phosphate buffers 
of pH6.5-7.5 are thus frequently used in hybridisation mixtures. 
The rate of renaturation also depends on the concentration of Na+ 
ions in the hybridisation buffer. These ions interact
electrostatically with phosphate groups of DNA nucleotides and 
decrease the electrostatic repulsion between the two strands of 
DNA, stabilizing it. For this reason, lower Na+ ion
concentrations are preferred. The presence of citrate in the 
hybridisation buffer prevents the action of free divalent 
cations which may strongly stabilise the DNA double helix.
The action of deionized formamide has been previously described 
(section 7.1). Its presence decreases the rate of hybridisation 
and lowers the melting temperature of DNA so that hybridisation 
may take place at lower temperatures over a longer period of 
time. By varying the formamide concentration during the 
hybridisation step, the specificity of centromeric alphoid 
repeat probes for their target sequences may be increased. This 
results in a lowering of background signal noise.
Dextran sulphate in aqueous solution is strongly hydrated. Such 
hydration prevents probe DNA from accessing water which has the
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effect of concentrating the probes and increasing their 
reannealing rates.
The quality of the target preparation is also an important 
factor in determining hybridisation efficiency. Hybridisation 
intensity has been shown to decrease with increased storage of 
the slides in air as the chromosomes remain compact (Pinkel et 
al.1986) while any residual cytoplasm around metaphase cells 
will limit probe penetration.
2.6.4 Immunodetection
After hybridisation, the duplexes formed will be a result of 
perfectly matched sequences and also result from sequences that 
are less homologous. Before immunodetection can be carried out, 
post-hybridisation washes are performed on the slides. These 
washes serve to remove any probe that has hybridized to the less 
homologous sequences so as to reduce background noise. This may 
be done by varying the stringency of the washes, through 
manipulation of the salt concentration, formamide concentration 
and temperature.
During this step, the specificity of centromeric alphoid repeat 
probes for their target sequences may be increased by increasing 
the stringency of the washes (Lichteret al. 1991a).
2.6.4.1 Immunodetection of Biotin-labelled Probes
For the detection of biotinylated probes, fluorescein
isothiocynanate (FITC) coupled to avidin was used. In order to 
enhance the signal, an amplification step employing a 
biotinylated anti-avidin antibody was used followed by the 
addition once again of avidin-FITC.
Slides were blocked by the addition of 100^1 of blocking 
solution [ 4xSSC; 3% Bovine Serum Albumin (BSA); 0.1% Tween 20 
] to the area of hybridisation. A coverslip was applied and the
slides were incubated at 37°C in a moist chamber for 30 minutes.
The coverslip was removed and 100^1 of avidin-FITC (Vector 
Laboratories Inc., U.S.A.) [diluted 1:1000 in detection buffer 
(4xSSC; 1% BSA; 0.1% Tween 20)] (stock concentration of avidin-
FITC: 200(ig/ml)was added to the slides. A coverslip was applied 
to the hybridisation area and slides were incubated in a moist
chamber at 37°C for 30 minutes in the dark.
Coverslips were removed and slides were washes three times of 5
minutes each in 4xSSC,0.1% Tween 20 (freshly prepared) at 42°C in 
the dark.
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After washing, lOOjil of biotinylated anti-avidin antibody 
(Vector Laboratories Inc.,U.S.A.) (diluted 1:100 in detection
buffer) (stock concentration: 200nl/ml) was added to the slides. 
A coverslip was applied to the hybridisation area and slides
were incubated in a moist chamber at 37°C for 30 minutes in the 
dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in 4xSSC,0.1% Tween 20 at 42°C in the dark.
After washing, 100^1 of avidin-FITC, diluted as described above, 
was added to the slides. A coverslip was applied to the 
hybridisation area and slides were incubated in a moist chamber 
at 37°C for 30 minutes in the dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in 4xSSC,0.1% Tween 20 at 42°C in the dark.
Slides were counterstained with 4,6 Diamidino-2-phenylindole 
2HC1 (DAPI) (200ng/ml in 2xSSC) for 15 minutes on an orbital
shaker in the dark at room T°.
Slides were washed for 2 minutes in 2xSSC, 0.05% Tween 20 in the 
dark at room T° and then mounted in 30|il of Citifluor mounting 
medium (1% glycerol in PBS).
The signal provided by the avidin-FITC conjugate may be enhanced 
by repeating the above avidin-FITC/anti-avidin protocol until 
the desired signal is achieved. However, this procedure 
increases the background noise level as each amplification step 
provides approximately a six-fold increase in intensity, each 
avidin molecule having about six fluorescein molecules attached 
to it (Pinkel et al.1986).
2.6.4.2 Immunodetection of Digoxigenin-labelled Probes
In the detection of digoxigenin-labelled probes, two different 
protocols were investigated employing two different 
fluorochromes both emitting a red signal. Protocol 1 involved 
the use of the fluorochrome Rhodamine, while protocol 2 involved 
the use of the fluorochrome TRITC. The experimental procedure 
for the two protocols is the same.
Slides were blocked by the addition of 100(11 of blocking 
solution TNB [0.1M Tris-HCl pH7.2; 0.15M NaCl; 0.5% blocking 
reagent (Boehringer Mannheim, Germany) ] to the area of 
hybridisation. A coverslip was applied and the slides were 
incubated at 37°C in a moist chamber for 30 minutes.
The coverslip was removed and 100(xl of mouse monoclonal anti-Dig
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antibody (Boehringer Mannheim,Germany)(diluted 1:200 in 
TNB) (stock concentration: 200pg/ml) was added to the slides. A 
coverslip was applied to the hybridisation area and slides were 
incubated in a moist chamber at 37°C for 30 minutes. This step 
was the same for both protocols 1 and 2.
Coverslips were removed and slides were washed three times of 5 
minutes each in TNT (0.1M Tris-HCl pH7.2; 0.15M NaCl; 0.05%
Tween 20- freshly prepared).
Protocol 1: After washing, 100|il of sheep anti-mouse Ig-DIG 
(Boehringer Mannheim,Germany)(diluted 2:100 in TNB)(stock
concentration: 200jag/ml) was added to the slides.
Protocol 2: After washing, 100 [il of rabbit anti-mouse TRITC 
antibody (Sigma Diagnostics, U.S.A.) (diluted 2:100 in TNB) (stock 
concentration: 200jxg/ml) was added to the slides. A coverslip 
was applied to the hybridisation area and slides were incubated 
in a moist chamber at 37°C in the dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in TNT at 42°C in the dark.
Protocol 1: After washing, 100|il of anti-dig-RHODAMINE antibody 
(Boehringer Mannheim,Germany)(diluted 2:100 in TNB)(stock
concentration: 200jxg/ml) was added to the slides.
Protocol 2: After washing, lOOjal of goat anti-rabbit TRITC 
antibody (Sigma Diagnostics, U.S.A.) (diluted 4:100 in TNB) (stock 
concentration 200|xg/ml was added to the slides. A coverslip was 
applied to the hybridisation area and slides were incubated in a 
moist chamber at 37°C in the dark.
Coverslips were removed and slides were washed three times 5 
minutes each in TNT at 42°C in the dark.
Slides were counterstained with 4,6 Diamidino-2-phenylindole 
2HC1 (DAPI) (200ng/ml in 2xSSC) for 15 minutes on an orbital
shaker in the dark at room T°.
Slides were washed for 2 minutes in 2xSSC;0.05% Tween 20 in the 
dark at room T° and then mounted in 30|il of Citifluor mounting 
medium (1% glycerol in PBS).
2.6.4.3 Immunodetection For Dual FISH
The technique of dual FISH or two-colour FISH refers to the 
simultaneous hybridisation of both biotin-labelled probes and 
digoxigenin-labelled probes to the same slide. Immunodetection 
of these labels proceeded as described in section 6.4.2. but
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antibodies specific for the two labels were prepared together in 
the same detection buffer and concentrations were adjusted 
according to the number of slides. The biotin immunodetection 
was applied with digoxigenin immunodetection protocols 1 and 2.
Slides were blocked by the addition of lOOjil of blocking 
solution TNB to the area of hybridisation. A coverslip was
applied and the slides were incubated at 37°C in a moist chamber 
for 30 minutes.
After washing, 100|il of mouse monoclonal anti-Dig antibody + 
avidin-FITC (diluted 1:200 and 1:1000 respectively in TNB) was 
added to the slides. A coverslip was applied to the 
hybridisation area and slides were incubated at 37°C in a moist 
chamber for 30 minutes in the dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in TNT at 42°C in the dark.
After washing, lOOjil of sheep anti-mouse Ig-DIG + biotinylated 
anti-avidin antibody (diluted 2:100 and 1:100 in TNB 
respectively)
or 100|il of rabbit anti-mouse TRITC + biotinylated anti-avidin 
antibody (diluted 2:100 and 1:100 in TNB respectively) was added 
to the slides. A coverslip was applied to the hybridisation area 
and slides were incubated at 37°C in a moist chamber in the dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in TNT at 42°C in the dark.
After washing, 100(il of anti-dig-RHODAMINE antibody + avidin- 
FITC (diluted 2:100 and 1:1000 respectively in TNB) or lOOjil of 
goat anti-rabbit TRITC + avidin-FITC (diluted 4:100 and 1:1000 
respectively in TNB) was added to the slides. A coverslip was 
applied to the hybridisation area and slides were incubated at 
37°C in a moist chamber in the dark.
Coverslips were removed and slides were washed three times of 5 
minutes each in TNT at 42°C in the dark.
Slides were counterstained with 4,6 Diamidino-2-phenylindole 
2HC1 (DAPI) (200ng/ml in 2xSSC) for 15 minutes on an orbital 
shaker in the dark at room T°.
Slides were washed for 2 minutes in 2xSSC;0.05% Tween 20 in the
dark at room T° and then mounted in 30|il of Citifluor mounting 
medium (1% glycerol in PBS).
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2.7 FLUORESCENCE MICROSCOPY
Slides were viewed by fluorescence microscopy using an Olympus 
BH2-RFCA microscope. FITC signals were detected using a FITC 
filter. Rhodamine and TRITC signal were detected using a TRITC 
filter and for dual FISH a triple filter was used. Cells were 
photographed using Scotch CHROME 640-T Colour Slide film.
2.8 GENE DOSAGE STUDIES
This study was undertaken to determine whether or not candidate 
genes involved in the translocation on chromosome 11 were either 
deleted, present in normal dosage or amplified. For the purposes 
of this study, DNA extraction and Slot Blot Assay techniques 
were employed.
Cell lines UW0V2 and UW0V2(Sf) were tested in this study. Human 
peripheral blood lymphocyte DNA was used as a contro^.
The probe used in this study was the human IGF-II probe mapping 
to chromosome llpl5.5. As a control, the p-actin gene probe 
pHFPA-1 was used. This cDNA probe represents a 1.9-2.1 kb insert 
of the human fibroblast cytoplasmic p-actin gene mapping to 
chromosome 7 (Ponte, H.et al.1984).
2.8.1 DNA Extraction
Cell cultures of UW0V2 and UW0V2(Sf) were grown until confluent. 
The supernatant was removed and cells were exposed to 0.25% 
trypsin in PBS at 37°C for 5-15 minutes until the cells lifted 
off the flask. Cells were washed in Hank’s Balanced Salts
Solution by centrifugation at 1400rpm for 10 minutes at room T°.
Human peripheral blood was collected and layered onto a 100% 
Hypaque-Ficoll-1077 solution (Sigma Diagnostics ,U.S.A.) and 
centrifuged at 1750rpm for 30 minutes in a Beckman GS-6R 
benchtop centrifuge. The A band was collected and washed twice 
in Hanks Balanced Salt Solution.
The pellets were resuspended in Amniocyte Buffer (50mM Tris-HCl 
pH7.6, lOOmM NaCl, ImM EDTA pH8.0, 0.5% SDS). To this, 0.05mg of 
proteinase K (Boehringer Mannheim, Gemany) was added and cells 
were incubated at 56°C for 4 hours.
2.8.1.1 Phenol/Chloroform Extraction
After incubation, 0.5 vol of phenol (Appendix A) and 0.5 vol of 
chloroform (chloroform:isoamylalcohol 24:1) was added. Tubes 
were shaken and centrifuged at 3000rpm for 15 minutes at room T°. 
The aqueous phase was retained and the extraction procedure was 
repeated for a minimum of three washes until the debris at the
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interphase had been removed. An equal volume of chloroform was 
added to the aqueous phase. The tubes were shaken and
centrifuged at 3000rpm for 5 minutes at room T°. The aqueous 
phase was removed and the DNA was precipitated by the addition 
of I / 2 0 V 0 I  of sodium acetate pH4.6 and 2*svol ice-cold ethanol. 
The mixture was incubated at -70°C for 15 minutes and centrifuged 
at 5000rpm for 15 minutes. The pellet was rinsed in 70% cold 
ethanol and the pellet was air-dried.
The pellet was resuspended in TE pH7.6 and stored at 4°C.
2.8.2 SLOT BLOT ASSAY
2.8.2.1 DNA Preparation
DNA samples of UWOV2, UWOV2(Sf) and peripheral blood lymphocytes 
were adjusted so that the final concentration for each sample 
was the same. Aliquots of 75ng, 150ng, 300ng and 600ng of DNA 
were prepared and made up to a final volume of 200(il in ION NaOH 
+ 0.5M EDTA.
2.8.2.2 Blot Preparation
Hybond-N paper (Amersham, U.K.) was cut to the exact dimensions 
of the blotting apparatus. For each probe that was to be tested, 
a single membrane was prepared. In addition to the membrane, two 
pieces of Whatmann filter paper were prepared having the same 
dimensions as the membrane. The filter paper and membrane were 
dipped into 20xSSC and then placed into the blotting apparatus. 
A vacuum was passed through the membrane until all excess liquid 
had been removed.
2.8.2.3 Blotting Procedure
The 200^1 DNA samples were denatured by heating on a hotplate at 
95°C for 5 minutes and then loaded into wells of the blotting 
apparatus. A vacuum was passed through the membrane and then the 
wells were washed three times by the addition of 400(^ 1 of 20xSSC 
and between each wash, a vacuum was passed through the membrane. 
After this, the blots were removed, air-dried and then baked at
80°C for 2 hours.
2.8.2.4 Probe Labelling
Probes IGF-II and p-actin were prepared by placing 50ng of probe 
DNA into a 45|J,1 volume of TE pH 7.6.
Labelling of probe DNA with P32 was carried out using the 
Rediprime random primer labelling kit (Amersham, U.K.). Briefly,
45|il of probe DNA was added to 5jal of [32-P] dCTP and mixed by
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gently pipetting. The tubes were incubated for 10 minutes at 37°C 
in order for the label to be incorporated. The labelled probes 
were purified by elution through Sephadex G-50 columns as 
described in section 2.5.1.
The samples were then tested for radioactivity using a Geiger 
counter.
2.8.2.5 Prehybridisation of the Blots
Blots were prehybridised in prehybridisation solution [5xSSPE 
(Appendix A), 5x Denhardt's solution, 0.5% (w/v) SDS, pre-heated 
to 65°C] . To this, 0.5ml of a lmg/ml solution of denatured salmon 
testes DNA (Sigma Diagnostics, U.S.A.) was added. Denaturation 
of the salmon testes DNA was by boiling for 5 minutes and then
chilling on ice. Blots were prehybridized for 1 hour at 65°C.
2.8.2.6 Hybridisation
Blots were removed from the prehybridization solution and placed 
into hybridisation bags (GibcoBRL, U.S.A.) and hybridisation 
solution [5xSSPE, 5x Denhardt's solution, 0.5% (w/v) SDS, 0.5ml
denatured salmon testes DNA (lmg/ml) was added.
Labelled probes were denatured by boiling for 5 minutes and were 
then added to the hybridisation mixture. The bags were sealed 
and incubated overnight at 65°C.
2.8.2.7 Post-hybridisation Washes
After hybridisation, blots were removed and washed twice in 
2xSSPE, 0.1% (w/v) SDS at room T° for 10 minutes each followed by 
one wash in lxSSPE, 0.1% (w/v) SDS at 65°C for 15 minutes.
2.8.2.8 Autoradiography
After washing, blots were sealed in plastic and autoradiography 
was carried out by exposure to X-ray film at -70°C for one week.
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SECTION 3.0
RESULTS
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Previously, cytogenetic analysis of cell line UW0V2(Sf) revealed 
the presence of two marker chromosomes harbouring p arm 
abnormalities being on chromosomes 1 and 11 (Golombick et 
al.1990). The chromosomal origin' of this additional material 
was not fully elucidated. This present study confirms these 
previous reports but the chromosome 1 abnormality appeared to 
involve the q arm.
In this study, cytogenetic analysis of G-T-G banded slides 
revealed several other structural and numerical clonal 
abnormalities which were present in every cell analysed (Figure 
2) . The structural abnormalities included a lq+, 7q-, 8q+, llp+, 
14q+ and 16q-. The numerical abnormalities observed included 
trisomy 5, trisomy 8, trisomy 12, trisomy 14, partial trisomy 7, 
monosomy 15, monosomy 18, and monosomy X. Several marker 
chromosomes of unknown origin were also observed.
Cytogenetically, the chromosomal origins of the lq+ and 8q+ 
abnormalities were unclear while the 14q+ appeared to be 
composed of chromosome 14 material.
The chromosomal origin of the llp+ abnormality could not be 
determined cytogenetically, however, the breakpoint of the 
abnormality appeared to involve the region llpl5. The 
representative karyotype for this cell line as determined by 
this study is as follows:
50-56,X, -X, add(1) (q42), t (3;10) (pl2-14/qll), +5,
del(7) (q21q36) , +8, add(8)(q23), add(8)(q23), 
der(ll)t(11/?)(pl5;?), +12, add(14)(q32), -15, 
del (16) (q24), -18, mar
3.1 Cytogenetic Analysis of Cell Line UW0V2(Sf)
3.2 Cytogenetic Analysis of Parent Cell Line UWOV2
Previously, cytogenetic studies on the parent cell line UWOV2 
revealed the presence of an llp+ abnormality considerably larger 
than that found in the subline UWOV2(Sf). The chromosomal origin 
of this marker was unknown (Golombick et al.1990). Cytogenetic 
analysis of G-T-G banded slides in this present study revealed 
the additional material to be composed entirely of chromosome 3 
(Figure 3) thus implying a t(3;ll) translocation. 
Cytogenetically, the breakpoints of this translocation appeared 
to involve the regions llpl5 and 3pl2-14 respectively. It was 
not possible however, to determine whether or not the chromosome 
11 abnormalities in the two cell lines arose independently of 
one another.
Full karyotypic data on this cell line was difficult to obtain 
as cells were often polyploid in number and clumped making an 
accurate analysis difficult and thus a representative karyotype 
was not obtained.
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UW0V2 SP'i
Figure 2: G-T-G-banded karyotype of a metaphase cell from cell 
line UW0V2(Sf) showing the clonal structural abnormalities (arrows).
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UWOV2
Figure 3: Partial G-T-G-banded karyotype from cell line UWOV2 
showing the chromosome 11 abnormality der(11)t (3;11) and a 
cytogenetically normal chromosome 3.
Karyotypic information on fresh tumour material used in this 
study was difficult to obtain. In the cases of tumours T2 and 
T4, no information was obtained due to difficulties in isolating 
a pure cell culture. Firstly, after 16-24 hours in culture there 
appeared to be an overgrowth of fibroblast cells. Such 
contamination by fibroblast cells can usually be removed by 
differential trypsinization but such a procedure requires long­
term culture conditions which could have introduced further 
genetic variation into the cells. Secondly, the seeding density 
of tumour cells is important in selecting for a pure cell 
population. In the cases of tumours T2 and T4, the seeding 
densities were low due to an insufficient amount of specimen 
material. Thus all metaphase cells analysed from these tumours 
appeared to be cytogenetically normal and of fibroblastoid 
origin.
Cytogenetic analysis of tumour T5 revealed a clonal abnormality 
involving a deletion on the long arm of chromosome 6. The 
abnormality appeared to involve the region 6q21. A single giant 
marker chromosome of unknown origin was also present in several 
but not all cells (Figure 4a) while additional markers were 
observed in other cells (Figure 4b) . Cytogenetically, chromosome 
11 appeared normal and was not involved in any structural or 
numerical abnormalities. The representative karyotype for tumour 
T5 is as follows:
44,XX, del(6)(q21q27) 2-3 mar
3.3 Cytogenetic Analysis of Fresh Tumour Material
3.4 Cytogenetic Analysis of Ascitic Fluid Cultures
Ascitic fluid cultures AF-1, AF-2, AF-3 and AF-5 showed an 
abundance of fibroblastoid-like cells after 24 hours in culture 
(Figures 5a-d) . Harvests of AF-1, AF-2 and AF-3 did not yield 
any cytogenetically analysable metaphases.
Ascitic fluid culture AF-5 was the only cytogenetically 
analysable culture yielding a perfect karyotype of 46 XX in all 
cells analysed (results not shown). This could be representative 
of a normal fibroblast cell.
3.5 FISH Studies on Cell Line UWOV2 (Sf)
Results of FISH studies using chromosome libraries to identify 
the chromosomal origin of the llp+ abnormality are summarised in 
Table II. In each case, a minimum of twenty cells were analysed 
for consistency. The result of FISH studies using the chromosome 
11 library probe may be seen in Figure 6.
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The FISH results showed that the marker chromosome lq+ 
abnormality was derived from chromosome 1 material (results not 
shown). The trisomy 5 and trisomy 12 observed cytogenetically 
were confirmed in these FISH studies. FISH results using the 
chromosome 7 library revealed that the chromosome 7q deletion 
did not appear to be as a result of a translocation event, as 
the deleted portion appeared to be lost from the cell line 
(results not shown).
1 CHROMOSOME LIBRARY HYBRIDISATION 
SIGNAL WITH MARKER 
CHROMOSOME 11
OTHER CHROMOSOMAL 
ABNORMALITIES
chromosome 1 - Iq+
chromosome 3 + der(10)t (3;10)
der(8)t (3;8)
der(11)t (3;8;11) |
chromosome 5 - + 5
chromosome 6 -
chromosome 7 - partial trisomy 7; 
7q -
chromosome 8 + + 8; der(8)t (3;8) 
der(11)t (3;8;11)
chromosome 9 -
chromosome 10 - der(10)t (3;10)
chromosome 11 + der(11)t (3;8;11)
chromosome 12 - + 12
chromosome 13 -
chromosome 14 - +14; 14q+
chromosome 15 - -15
I chromosome 16 - 1 6 q- 1
I chromosome 17 -
chromosome 19 -
chromosome 21 -
chromosome 22 -
| chromosome X - -X
Table II: Results showing the hybridisation signal between the 
chromosomal libraries and the marker chromosome 1 1  as determined 
by Fluorescence in situ hybridisation studies with cell line 
UW0V2(Sf).
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Figure 4a: G-T-G-banded karyotype of a metaphase cell from 
specimen T5 showing the abnormality del(6)(q21q27) (arrow) and 
a single giant marker chromosome (MAR).
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Figure 4b: G-T-G-banded karyotype of a metaphase cell from 
specimen T5 showing the abnormality del(6)(q21q27) (arrow). Two 
marker chromosomes are present.
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Figure 5a: Cells from ascitic fluid culture AF-l showing a 
fibroblastoid-like morphology (Giemsa stain x400).
Figure 5b: Cells from ascitic fluid culture AF-2 showing a 
fibroblastoid-like morphology (Giemsa stain x400).
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Figure 5c: Cells from ascitic fluid culture AF-3 showing a 
fibroblastiod-like morphology (Giemsa stain x400).
Figure 5d: Cells from ascitic fluid culture AF-5 showing a 
fibroblastoid-like morphology. Multinucleated cells are present 
(arrow) (Geimsa stain x400).
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Studies using the chromosome 3 library probe showed that 
chromosome 3 was involved in several structural abnormalities 
including positive hybridisation to the proximal portion of the 
chromosome llp+ abnormality. The additional material on 
chromosome 8 (as detected cytogenetically) was found to be of 
chromosome 3 origin, and the t(3;10) observed cytogenetically 
was also confirmed using FISH (Figure 7).
Analysis of chromosome 8 revealed that it was involved in a 
translocation event with chromosome 3 and hence the 8q+ detected 
cytogenetically. This t(3;8) was present in two of the three 
copies of chromosome 8 present in each cell. After screening 
using single colour FISH, dual FISH was used to confirm the 
t(3;8) event. It also showed positive hybridisation to the 
distal portion of the chromosome lip abnormality (Figure 8 ) .
The llp+ abnormality was thus found to consist of derivatives 
from chromosomes 3 and 8 indicating a complex translocation 
t(3;8;ll) the distal portion of the marker being of chromosome 8 
origin and the proximal portion being of chromosome 3 origin 
(figure 9). The breakpoint of the t(3;ll) could not be 
accurately determined from this screening study while the t(3;8) 
appeared to involve the regions 8q22-24 on chromosome 8 and 
3ql2-21 on chromosome 3.
The chromosome 14q+ abnormality showed positive hybridisation 
with the chromosome 14 library probe (figure 10) and appeared to 
involve the region 14q32. Chromosome 16 was consistently deleted 
in the region 16q24 in all cells analysed (results not shown).
Based on the FISH results obtained in this study, a revised 
karyotype of cell line UWOV2(Sf) may be described as follows:
50-56,X, -X, add(1)(q42), der(10)t (3;10), +5, del(7)(q21q36),
+ 8 , der(8)t(3;8) (ql2-21,q22-24), der(8 )t (3;8 ) (ql2- 
21;q22-24), der(11)t (3;8 ;11) (pl2-14;q22-24;pl5) , +12, 
add(14)(q32), -15, del(16)(q24), -18, mar
3.6 FISH Studies on Cell Line UWOV2
After the chromosomal origin of the llp+ abnormality in cell 
line UWOV2(Sf) was elucidated, the abnormality in the parent 
line UWOV2 was screened using chromosome 3 and chromosome 8 
library probes. This abnormality was found to be composed 
entirely of chromosome 3 material and was negative for 
chromosome 8 material, thus confirming the cytogenetic findings. 
Chromosome 3 did not appear to be involved in any other 
abnormalities and two normal copies of chromosome 3 were present 
in each cell in addition to the t(3;ll).
A chromosome 8a centromeric probe was used to determine the copy 
number of chromosome 8 in this cell line. FISH studies revealed
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Figure 6: Biotinylated whole chromosome 11 library probe 
hybridized to a metaphase cell of cell line UW0V2 (Sf) showing the 
llp+ abnormality (arrow) and a normal chromosome 11 (DAPI 
counterstain xlOOO).
Figure 7: Biotinylated chromosome 3 library probe and 
biotinylated chromosome 11 centromeric probe hybridized to a 
metaphase cell of cell line UW0V2(Sf) showing positive 
hybridization of chromosome 3 material to the distal portion of 
the llp+ abnormality (arrow). Several other structural 
abnormalities involving chromosome 3 are present (DAPI 
counterstain, FITC filter xlOOO).
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Figure 8 : Dual FISH with biotinylated chromosome 8 library probe 
and Dig-labelled chromosome 3 library probe on a metaphase cell 
from cell line UW0V2(Sf) showing the t(3;8) and positive 
hybridization of the chromosome 8 probe and feint hybridization 
of the chromosome 3 probe to the distal portion of the llp+ 
abnormality (arrows) (DAPI counterstain, triple filter xlOOO).
Figure 9: Dual FISH with a chromosome 8 library probe (FITC 
signal) and a chromosome 11 library probe (Rhodamine signal) to 
a metaphase cell of cell line UWOV2(Sf) showing chromosome 8 
material on the distal portion of the llp+ abnormality (DAPI 
counterstain, triple filter xlOOO).
page 59
Figure 10: Biotin-labelled chromosome 14 library probe hybridized 
to a metaphase cell of cell line UW0V2(Sf) showing trisomy 14 
(arrows) and 14q+ (DAPI counterstain, FITC filter xlOOO).
Figure 11: Biotin-labelled chromosome 8 centromeric probe 
hybridized to a metaphase cell of cell line UW0V2 showing three 
cytogenetically normal copies of chromosome 8 (arrows) (DAPI 
counterstain, FITC filter xlOOO).
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Figure 12: Biotin-labelled chromosome 11 centromeric probe and 
pSBp gene probe hybridized to a metaphase cell of cell line 
UW0V2(Sf) showing positive hybridization of pSBp to the normal 
chromosome 11 (arrow) (DAPI counterstain, triple filter xlOOO).
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Figure 13: Biotin-labelled YAC probe 847al2 hybridized to a 
normal metaphase cell showing FITC signals at the distal portion 
of chromosome llpl5 (arrows) (DAPI counterstain, triple filter 
xlOOO) .
Figure 14: Biotin-labelled YAC probe 954f4 hybridized to a normal 
metaphase cell showing FITC signals at the distal portion of 
chromosome llpl5 (arrows) (DAPI counterstain, triple filter 
xlOOO) .
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Figure 15: Biotin-labelled YAC probe 845a3 hybridized to a normal 
metaphase cell showing FITC signals at the region llpl5.1 
(arrows) (DAPI counterstain, triple filter xlOOO).
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Figures 16a & b: Metaphase cells of cell line UW0V2(Sf) showing 
hybridization of biotin-labelled YAC probe 845a3 to the 
chromosome llp+ abnormality (arrows) and to the normal chromosome 
11 (DAPI counterstain, FITC filter xlOOO).
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Figure 17: Metaphase cell of cell line UW0V2(Sf) showing 
hybridization of the biotin-labelled YAC probe 966e8 to the 
normal chromosome 11 but not to the chromosome llp+ abnormality 
(arrows) (DAPI counterstain, triple filter xlOOO).
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there to be three copies of chromosome 8 which appeared 
cytogenetically normal as revealed by DAPI counterstaining 
(Figure 11) .
3.7 Mapping of the Breakpoint in Cell Line UWOV2 (Sf) Using FISH 
Studies
Initially, mapping of the t(3;ll) on chromosome 11, proceeded in 
a pter—»pcen direction. Using FISH, the single copy gene probe 
pSB|3 mapping to the region llpl5.5 showed feint positive 
hybridisation to the normal chromosome 11 homologue, but no 
signal was detected on the marker chromosome 11 suggesting that 
the breakpoint of the t(3;ll) lay proximal to this region 
(Figure 12).
CEPH YAC probes 892g9, 785e5, 847al2 and 954f4 were used for
mapping. Results on control slides using YACs 847al2 and 954f4 
revealed strong signals in the region llpl5 with no non-specific 
hybridisation (Figures 13 and 14) . FISH studies on cell line 
UW0V2(Sf) showed no signal on the marker chromosome 11 (results 
not shown) indicating that the breakpoint lay proximal to the 
region llpl5.4. The signal intensity of the different YAC probes 
differed considerable due to the quality of the probes and the 
quality of the target cells.
Using YAC probe 845a3 and the more distal YAC probe 966e8, FISH 
results on control slides using these probes revealed signals in 
the region llpl4.3-15.1 (figure 15) with no non-specific
hybridisation. Results with probe 845a3 are not shown.
FISH studies on cell line UWOV2 (Sf) with YAC 845a3 showed 
hybridisation to both the marker chromosome 11 and its normal 
homologue (Figures 16a & b) . FISH studies with the more distal 
YAC 966e8 showed no hybridisation to marker chromosome 11 but a 
signal was detected on the normal homologue (Figure 17) . From 
these results it was deduced that the breakpoint of the t (3; 11) 
lay in the region between and/or incorporating the regions 
spanned by YACs 845a3 and 966e8. This corresponds to the region 
llpl4.3-15.1 according to the physical integration map of 
Bickmore et al.1995 (figure 22). A map of chromosome lip showing 
the regional allocations of the various probes used in this 
study can be seen in figure 23.
Dual FISH using the two probes 845a3 and 966e8 on interphase 
cells of UWOV2(Sf) confirmed the above results (Figures 18a & 
b) .
3.8 Mapping of the Breakpoint Region in Cell Line UWOV2 Using 
FISH Studies
Based on the mapping results obtained with cell line UW0V2(Sf), 
YACs 845a3 and 966e8 were also hybridized to cell line UW0V2 to 
determine whether or not the breakpoints were the same. Results
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Figure 18 (a & b) : Dual FISH on interphase cells of cell line 
UW0V2(Sf) with YAC probe 845a3 (FITC signal) and 966e8 (Rhodamine 
signal) (arrows) (DAPI counterstain, triple filter xlOOO)
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Figure 19: A hypodiploid metaphase cell of specimen T5 showing 
dual FISH with YAC probes 845a3 (FITC signal) and 966e8 
(Rhodamine signal) (DAPI counterstain, triple filter xlOOO) .
Figure 20: A hypodiploid metaphase cell of specimen AF-5 showing 
dual FISH with YAC probes 845a3 (FITC signal) and 966e8 
(Rhodamine signal) (DAPI counterstain, triple filter xlOOO)
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Figure 22: A physical integration map of a portion of the region 
lip14.3-pl5.1 indicating the possible position of the t(3;ll) 
breakpoint region on chromosome 11 in cell lines UW0V2 and 
UW0V2(Sf) relative to the two YAC probes 845a3 and 966e8 
(Reproduced from Bickmore et al. 1995).
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Figure 23: A map of the distal portion of chromosome llpl5 
showing the position of the YAC probes used in this study 
relative to various DNA markers. The region of the t(3;ll) 
breakpoint is indicated (Reproduced from James et al. 1994).
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showed that probe 845a3 hybridized to both the marker chromosome 
11 and its normal homologue while hybridisation of probe 966e8 
yielded a signal from the normal chromosome 1 1  only (results not 
recorded due to rapid fading of the signal). From this it can be 
assumed that the t(3;ll) breakpoints in the parent cell line and 
its subline lie in the same region llpl4.3-15.1.
3.9 FISH Analysis of Fresh Tumour Material
Cytogenetic analysis of tumour T5 revealed two cytogenetically 
normal copies of chromosome 11. Results of dual FISH using YAC 
probes 845a3 and 966e8 showed no detectable abnormalities 
involving the region llpl4.3-15.1 (Figure 19). Results of dual 
FISH using YAC probes 845a3 and 966e8 on ascitic fluid culture 
AF-5 showed no abnormalities in this region (Figure 20). In both 
cases, cells were hypodiploid and in all cells analysed, only 
one homologue of chromosome 11 was present. All of these 
homologues however yielded a normal result.
3.10 Gene Dosage Studies
Results of gene dosage studies can be seen in Figure 21. In 
figure 21a, hybridisation of probe IGF-II to cell line UWOV2(Sf) 
(lane 1) and UWOV2 (lane 3) yielded weaker signals compared to 
the control DNA (lane 2). Although differences in signal 
intensity between control and cell line DNA could be discerned, 
this was not evidence enough to support the possibility that the 
region incorporating the IGF-II gene locus on llpl5.5 was lost 
from cell lines UW0V2 and UWOV2(Sf) on marker chromosome 11.
Figure 21b shows results with the p-actin gene probe. A 
significant difference in signal intensity could not be 
accurately discerned.
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Figure 21: Autoradiograph of slot blot assays with probes IGF-II 
(a) and p-actin ( b ) . Lane 1 indicates cell line UW0V2(Sf) DNA, 
Lane 2 indicates control DNA and Lane 3 indicates cell line UW0V2 
DNA.
SECTION 4.0
DISCUSSION
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The genetic changes occurring during epithelial ovarian cancer 
are not well understood although the role of many known cellular 
oncogenes and tumour suppressor genes have been investigated. 
This study served to define more accurately the role that 
chromosome 1 1  abnormalities play in the pathogenesis of 
epithelial ovarian carcinoma. Using FISH techniques, the 
breakpoint of a complex translocation in two ovarian cancer cell 
lines was mapped successfully in a process that proved to be 
both rapid and reliable.
4.1 Cytogenetic Analysis of the lip Abnormality in Cell Lines 
UWOV2 and UWOV2 (Sf)
The nature of the chromosome lip abnormality in cell line UW0V2 
could not be clearly determined cytogenetically. The difficulty 
in identifying the abnormality in this study and in that of 
Golombick et al.1990, may have been in part due to the inability 
to detect the chromosome 3 centromere. Metacentric chromosome 
centromeres may become unstable and lose their functionality 
during translocation events. The dicentric nature of the 
abnormality could thus not be seen.
4.2 FISH Analysis of Cell Lines UWOV2 and UWOV2(Sf)
Using the dual FISH detection system and DAPI banding in 
conjunction with YAC probes, the t (3;11) breakpoint region in 
cell line UWOV2(Sf) could be assessed quite rapidly. Through 
conventional cytogenetic methods, the chromosomal origin of this 
complex translocation could not be determined. The technique of 
screening with chromosomal libraries may be applied to all types 
of human tumour cells exhibiting complex karyotypes. Using FISH, 
we were also able to trace the clonal evolution of the llp+ 
marker chromosome from the parent line to the subline.
In this study, several of the results could not be graphically 
depicted. This may have primarily been due to a) rapid fading of 
the fluorescent signal b) technical problems encountered during 
photographing the results and c) inconsistencies in the 
hybridisation efficiency of the various whole chromosome library 
probes - this phenomenon was clearly outlined by Gray et 
al.1991. These problems were encountered especially during the 
dual FISH hybridisation experiments where the result could not 
be amplified after signal loss. Such a situation thus required 
the specific experiment to be repeated.
Problems were encountered with the batch of Rhodamine obtained 
from the manufacturer who agreed that problems of rapid signal 
fading had been encountered by themselves and other observers.
The two dual FISH protocols employing either Rhodamine or TRITC 
together with FITC appeared to be equally successful however, 
the Rhodamine signals tended to fade much more rapidly, for
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reasons described above, while the TRITC which provided more 
unwanted background staining, tended to be more stable under 
epifluorescent microscopy.
The presence of the marker 11 chromosome harbouring the t(3;ll) 
abnormality in the parent cell line UW0V2 and the t(3;8;ll) 
abnormality in the subline UW0V2(Sf) leads us to speculate that 
the t(3;8) in the subline was an acquired abnormality as a 
result of in vitro cell culture under serum free conditions. 
This hypothesis may be supported by the observation that UW0V2 
revealed three copies of chromosome 8 which appeared 
cytogenetically normal (Golombick et al.1990). The growth 
advantage conferred by the t(3;8) on UWOV2(Sf) remains to be 
elucidated. This region however is of interest as it harbours 
the c-myc proto-oncogene on chromosome 8q whose fusion with a 
yet undefined gene on chromosome 3q may directly or indirectly 
lead to the production of a known growth factor or novel growth 
factor which may allow propagation of this cell line under serum 
free conditions.
From the FISH results, it may be assumed that loss of chromosome 
11 material distal to llpl5.1 occurred on marker chromosome 11 
in both cell lines UWOV2 and UWOV2(Sf). This assumption however 
could not be confirmed using slot blot assays which yielded an 
ambiguous result.
The involvement of chromosome 3 in this translocation has 
numerous implications regarding observations made in 
genitourinary cancers and the breakpoint region involved here 
has been implicated in several other human cancers. Besides 
being implicated in contributing to the malignant phenotype in 
ovarian carcinomas, cytogenetic abnormalities and molecular 
genetic changes involving this chromosome have been implicated 
in the development of lung (Brauch et al. 1990), and renal cell 
carcinomas (Latif et al.1993). Several reports have detailed 
these chromosomal changes in ovarian carcinoma (Teyssier et 
al.1987; Tanaka et al.1989) and LOH studies have revealed common 
regions of deletion on 3p (Ehlen, T; Dubeau, L.1990). These 
reports have mainly detailed loss of heterozygosity studies, 
unbalanced translocations and numerical abnormalities involving 
chromosome 3 and the regions on chromosome 3 which are 
implicated in the translocation events observed in the cell 
lines in this study.
Deletions and unbalanced translocations involving the regions 
3pl3-21 (Pejovic et al.1992), 3pl0-23 (Thompson et al.1994) and 
3p21-26 (Jenkins et al.1993) were described (figure 24). 
Thompson et al. 1994, found that a + del(3p) was the only 
abnormality present in a patient with stage I ovarian cancer 
suggesting a role for this chromosome in early tumour 
progression in some patients. Bello et al.1990 describes a case 
in which the sole karyotypic abnormality in an ovarian cancer 
patient was trisomy 3. These findings may be extrapolated to
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those of our study where trisomy 3 may have been present in vivo 
before UW0V2 and subsequently the subline UW0V2(Sf) may have 
acquired the t(3;ll) event.
pter
—  breakpoint region t(3;ll)
CEN
Figure 24: A map of the short arm of chromosome 3 indicating the 
various regions implicated in ovarian carcinoma. The position of 
the t (3;1 1 ) breakpoint is indicated.
The loss of chromosome 3p sequences has been shown to be the 
most characteristic and possibly the first genetic event in the 
development of non-papillary renal cell carcinoma (RCC). 
Initially it was though that the gene responsible for RCC had 
been found (Latif et al.1993) and the putative TSG, the VHL gene 
was cloned and assigned to the region 3p25-26. Alterations in 
this gene are responsible for von Hippel-Lindau disease, a 
dominantly inherited familial cancer syndrome and the most 
common form of RCC (Maher et al.1991). Other studies however 
point to the regions 3pl2-14 and 3p21 as harbouring a second or 
other putative TSGs (Sanchez et al.1994) implying that several 
genes may be involved in this condition. The region 3pl4.2 
involves the t(3;8) translocation breakpoint implicated in both
page 76
familial and sporadic forms of RCC and this translocation event 
has been hypothesised to affect the expression of an RCC TSG or 
oncogene (Boldog et al.1993). Huebner et al.1995 implicated 
other yet undefined loci in the region 3pl2-14 responsible for 
RCC. Kovacs et al.1995 state that these studies suggest that the 
mechanism of tumourigenesis may be due to several events:
- a cluster of TSGs are present in the region 3pl2-14
- a translocation event has a positional effect on a TSG in the
region of the breakpoint
- the breakpoint directly affects a TSG in the region
Allele-specific chromosome 3 deletions have also been shown to 
occur at an early stage in the pathogenesis of lung carcinoma. 
The most common changes in small cell and non-small cell lung 
carcinomas involve loss of genetic material at three distinct 
regions located at 3p25, 3p21.3 and 3pl4—>cen (Brauch et al.1990; 
Thiberville et al. 1995). The VHL gene shows few mutations in 
lung carcinoma and therefore there may be another recessive 
oncogene at the 3p25 region. Hung et al. 1995 showed that 3p 
allelic loss occurs at the very earliest preneoplastic stage in 
lung cancer.
The connection between the breakpoint on 3pl2-14 in cell lines 
UW0V2 and UW0V2(Sf) and those described above are purely 
speculative. Although the exact breakpoint region of the t(3;ll) 
in this study, remains to be mapped one cannot rule out a common 
TSG or cluster of TSGs in this region which may be necessary for 
the establishment of the malignant phenotype and may even be one 
of the first events in a series of genetic events leading to 
tumourigenesis. The frequent involvement of the region 3pl2-pl4 
in studies described above and the involvement of this region in 
the breakpoints described in this study leads one to speculate 
that there may be a region of involvement common to the 
pathophysiology of these cancers.
Trisomy 12 has also been described in ovarian carcinoma often as 
being the sole abnormality in a variety of these tumours both 
epithelial and non-epithelial, benign and malignant (Pejovic et 
al.1992). This includes ovarian fibromas and serous 
cystadenomas. Jenkins et al.1993 states that the frequent 
occurrence of trisomy 1 2  in non-epithelial ovarian tumours and 
its absence from more differentiated epithelial tumours is 
evidence for it not being an early obligatory event unique to 
epithelial tumours and that clones harbouring trisomy 1 2  appear 
to have a selective advantage in culture. The K-ras proto­
oncogene locus on 1 2 p is frequently activated in ovarian 
carcinomas but appears to be unrelated to the presence of 
trisomy 12 (Yang-Feng et al. 1991). Trisomy 12 has also been 
reported as being the sole abnormality in a case of Wilms’ 
tumour and is quite prevalent in this condition (Wang Wuu et 
al.1990).
page 77
Structural and numerical abnormalities involving chromosome 14 
are not commonly reported on in ovarian tumours. Besides the 
observations of Wake et al.1980, chromosome 14 has been reported 
to be involved in deletions and unbalanced translocations in 
several other reports on ovarian cancer (Jenkins et al.1993; 
Thompson et al.1994; Pejovic et al.1992). In our study, the 
additional material on 14q observed cytogenetically resulted 
from an amplification event (HSR) involving the region 14q31-32. 
This was confirmed by FISH studies. Its influence on cell line 
UWOV2(Sf) remains to be determined.
Cytogenetic analysis of the X chromosome in ovarian tumour 
specimens frequently identifies the loss of an X chromosome
often at quite high levels. Thompson et al.1994 suggests that 
chromosome X loss may be a primary or early event in
tumourigenesis. However, loss of an X chromosome may not be a 
prerequisite for tumourigenesis as seen in our study where
tumour specimen T5 exhibited two cytogenetically normal copies 
of this chromosome. A different hypothesis is that selective 
inactivation of X chromosome genes by hypermethylation may 
contribute to the inactivation of a tumours suppressor gene/s 
(Laird et al. 1994). The significance of the X chromosome in
ovarian tumours remains to be determined.
4.3 Mapping Studies on Chromosome lip
Chromosome lip has been well studied and mapped especially in 
the region Ilpl3-pl5.5 due to its involvement in Wilms1 tumour, 
aniridia, genitourinary, mental retardation (WAGR) syndrome and 
the Beckwith-Wiedemann syndrome (BWS). Several physical maps of 
the region llpl3-15 have been published (Redeker et al.1994) and 
a radiation hybrid map is also available (James et al.1994). The 
problem in comparing information from these maps has been that 
they use different sets of DNA markers or landmarks in their 
construction. The mapping data are expressed using differing 
distance units based on the methods used for example, kilobases, 
centiMorgan (cM) or centiRays (cR). It is therefore difficult to 
relate information from one source with that from another.
In our study, the regional assignments of CEPH YACs 845a3 and 
966e8 are in agreement with the physical integration map of 
Bickmore et al. 1995 (figure 22) and the radiation hybrid map of 
James et al.1994 (figure 23). This study thus confirmed that the 
two markers D11S1308 and D11S899 spanned by YAC 845a3 lie 
proximal to the two markers D11S902 and D11S921 which are 
spanned by the YAC 966e8. The physical distance, with reference 
to the physical map of Bickmore et al. 1995, between the most 
distal marker D11S899 (contained by YAC 845a3) and the most 
proximal marker of YAC 966e8, that is D11S921 corresponds to 
approximately 1 megabase. From the FISH results, it is apparent 
that the breakpoint of the t(3;ll) lies within this region just 
distal to YAC 845a3 but not including it. This is an assumption
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based on the observation that the signal intensity provided by 
this YAC on the marker chromosome 11 was as strong and the area 
covered appeared to be equal to that observed on the normal 
chromosome 11 homologue. One cannot however exclude the possible 
involvement of a smaller region contained within this YAC in 
this translocation.
Through Fluorescence in situ hybridisation analysis, YAC probes 
845a3 and 966e8 appeared to be in close proximity to each other. 
Although the observed distance between the two YACs may appear 
small on metaphase chromosomes, the actual distance is much 
larger due to the conformational state of the DNA double helix. 
Lichter et al. 1991a ordered probes on chromosome 11 in the 1 Mb 
range and states that this range may represent the border of 
resolution for metaphase mapping. Resolution may not be 
influenced only by chromosome length but also by variations of 
chromatin conformation at different chromosomal sites. Because 
of this, metaphase mapping may provide an ambiguous result in as 
far as measurements of distance between ordered probes is 
concerned. For the purposes of metaphase mapping, elongated 
prometaphase chromosomes are the ideal targets as the signals 
may then be better interpreted. The incorporation of a banding 
technique such as DAPI staining has allowed probes to be mapped 
with reference to the various chromosomal bands. Probes lying in 
the same latitude that is, those lying on the width of a 
chromosome on chromatids, may be better resolved on more 
condensed metaphase chromosomes. Mapping resolution may be 
further improved by analysis of chromosomal DNA in more 
decondensed states such as that found in interphase nuclei.
Dual FISH with YAC probes 845a3 and 966e8 on interphase cells 
revealed the two probes to be separated by a considerable 
distance while similar studies on elongated metaphase 
chromosomes showed the two signals to virtually coalesce into 
one. Interphase mapping may therefore prove to be a more 
reliable determinant of distance between ordered probes however, 
a large number of nuclei should be analysed as the 
decondensation states of the chromatin vary between nuclei. 
Besides this, only probes in close proximity to each other may 
be analysed with any amount of accuracy as the specific domains 
that each chromosome occupies within an interphase cell still 
remains to be determined.
The region on llpl5.1 in which the t(3;ll) breakpoint lies has 
not been well studied and characterized. Although YAC contigs 
and cosmid probes mapping to this region are available (van 
Heyningen et al.1995) few known genes or disease loci have been 
assigned to this region. The region as a whole is of particular 
interest in terms of the genetics of urinogenital cancers 
especially the childhood rhabdomyosarcomas, Wilms' tumour and 
Beckwith-Wiedemann syndrome (Slater et al.1992). Although the 
WT1 TSG at llpl3 was not shown to be altered in ovarian 
carcinomas (Viel et al.1994) the region llpl5 has been
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implicated in the harbouring of a second putative Wilms1 tumour 
TSG and its association with ovarian cancer is yet to be 
determined. Recently, three putative TSGs relative to Beckwith- 
Wiedemann syndrome associated chromosomal breakpoints have been 
mapped to llpl5.3 using FISH studies (Redeker et al.1995) and 
other studies have disclosed two clusters of breakpoints in the 
llpl5.4-llpter region (Henry et al.1989). From our results we 
speculate that a cluster of TSGs in the region llpl5 play an 
important role in the progression of these cancers and 
epithelial ovarian carcinoma.
4.4 Analysis of Fresh Tumour Material
The procedures employed in the cell culture of fresh tumour 
material and ascitic fluid proved to be suitable for most of the 
specimens and although only a few specimens yielded 
cytogenetically analysable metaphases, the ones that did, gave 
very informative results. The establishment of epithelial 
ovarian cancer cultures is usually problematic and sometimes the 
correct parameters have to be defined for each specimen. A 
drawback in this study was that the histopathology data for each 
specimen used was not obtained and therefore their 
classification according to the FIGO classification system was 
not established.
The cellular appearance of ascitic fluid cultures AF-1, AF-2, 
AF-3 and AF-5 were fibroblastoid in morphology and they were 
thus assumed to be normal fibroblast cells which had 
contaminated the preparation. Fresh tumour samples T2 and T4 
assumed a fibroblastoid-like morphology while T5 appeared to 
form a compact cobblestone monolayer characteristic of 
epithelial cells and epithelial ovarian tumour cells in culture. 
Although it may be assumed that the presence of fibroblasts in 
culture may have been due to contamination, studies have shown 
that epithelial phenotypes which the ovarian epithelial tumour 
cells exhibit In vivo may modulate to an atypical fibroblast­
like form in vitro, gradually under standard culture conditions 
(Auersperg et al.1984) or rapidly in response to epidermal 
growth factor (Siemens et al.1988). The appearance of 
epithelial cells in culture has also been shown to be influenced 
by the medium on which they are grown. The ability of these 
cells to modulate into a fibroblastoid-like appearance shows 
that these cells are far more complex and versatile than would 
be expected. Their mesodermal origin and their close 
relationship to stromal cells appears to confer on these cells 
the capacity to express a certain amount of plasticity by 
modulating between epithelial and fibroblastoid phenotypes as 
they are able to undergo epithelio-mesenchymal conversion upon 
interaction with specific substrates. The exact identity of 
these cells may have been determined by testing for ovarian 
cancer-specific antigens.
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Tumour T5 was the most informative of all the cultures. The only 
clonal abnormality - clonality being defined as two or more 
cells harbouring a specific defect - appeared to be a del(6q) 
involving the region 6q21. Abnormalities involving the long arm 
of chromosome 6 have been extensively described in ovarian 
carcinomas (Pejovic et al.1992; Thompson et al.1994). Wake et 
al. 1980 showed that in short term culture of ovarian 
seropapillary cyst adenocarcinomas from nine patients, five had 
the reciprocal translocation t (6;14)(q21;q24) and four had a 6q- 
marker chromosome. The results were of considerable interest as 
they represented the first clear indication of a structural 
chromosome specificity in any carcinoma. This 6q- was not 
limited to serous tumours and had previously been detected in a 
range of histologically different subtypes (Van der Riet-Fox et 
al.1979). Woods et al.1979, detected a similar 6q- marker in 
three out of four cell lines isolated from ovarian seropapillary 
adenocarcinomas, however previous studies on cell lines from 
similar carcinomas did not reveal the presence of this marker 
(Freedman et al. 1978) and this was confirmed in a later study 
(Hill et al.1984). Therefore the role of the 6q- in tumour 
pathogenesis could not be fully established.
Loss of heterozygosity studies reported subsequently on 
chromosome 6q has suggested that this region harbours an ovarian 
cancer associated TSG(s) and three regions have been implicated: 
6q24-27, 6q21-23 and 6ql2-16 (Lee et al.1990, Mok et al.1995).
The involvement of the region 6q21-23 in our study is 
significant considering the findings of Wake et al.1980 however, 
this region also harbours the proto-oncogene c-myb. Mok et
al. 1995 showed that this site may not be involved in the 
pathogenesis of borderline seropapillary carcinomas and Boyle et 
al.1995 implicated this region to be involved in benign tumours 
and endometroid tumours suggesting a possible involvement of 
this region early in the progression of these tumours. This 
finding is supported by the observation that the involvement of 
this region in later stage seropapillary carcinomas is
significantly reduced.
The region 6q24-27 is the most frequent region of LOH in 
invasive tumours and is of particular interest as it harbours 
the oestrogen receptor gene site. Studies have demonstrated that 
this region displays LOH of up to 75% (Lee et al.1990; Saito et 
al.1992; Dodson et al.1993; Foulkes et al.1993). Mok et al.1995 
demonstrated LOH at this region in only 29% of invasive tumours 
and found that this figure was significantly reduced in 
borderline tumours. This suggests the presence of a TSG which 
may be found in the vicinity of the oestrogen receptor gene but 
may not necessarily involve it directly as this locus did not 
appear to be deleted.
In tumour T5, the region 6q24-27 was lost in one homologue while 
deletions at this region on the normal homologue could not be 
detected cytogenetically. More information on the exact location
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of the breakpoint region on 6q may be obtained by mapping 
studies using YAC probes in combination with FISH.
The del(6q) has also been reported in other malignancies. 
Menasce et al.1994 showed in patients with acute lymphoblastic 
leukaemia (ALL) and non-Hodgkins lymphoma a deletion in the 
region 6ql6.3. Whether the same gene is involved or not in 
these two conditions is unknown.
The above studies thus point to the involvement of at least two 
regions on chromosome 6q that may be involved in the initiation 
and progression of different histological types of ovarian 
tumours.
The results with YAC probes 845a3 and 966e8 on T5 and AF-5 
confirmed the cytogenetically normal appearance of chromosome 1 1  
in these specimens, however, these results do not rule out the 
possibility of there being a subtle structural abnormality 
involving a gene in the region between the two probes that may 
contribute to the initiation or progression of the malignant 
phenotype. This may be assessed by further mapping and cloning 
of the breakpoint on chromosome llpl5.
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In this study, FISH proved to be a valuable technique in 
elucidating the nature of the llp+ abnormality in both cell 
lines, as being the complex translocation t (3;8;11) (pl2-14;q22- 
24;pl5.1) in UW0V2(Sf) and the translocation t(3;ll)(pl2- 
14;pl5.1) in UW0V2.
The success of Fluorescence in situ Hybridisation potentiates 
its application in the field of solid tumour work. The technique 
proved to be rapid and successful and thus solid tumours 
yielding complex karyotypes may be screened and the clonal 
development of structural and numerical abnormalities may be 
traced through the evolution of these tumours. An important area 
of application may be in the comparison between primary tumours 
and their metastases.
The results obtained in this study on the cell lines, highlight 
two chromosomal regions on two chromosomes critical to the 
pathophysiology of ovarian carcinomas and other human
malignancies. The region on chromosome llpl5.1 remains to be 
mapped further using cosmid probes or other YAC probes spanning 
the region between D11S899 and D11S921. This would allow the 
critical region to be narrowed down even more thus providing a 
handle to clone the breakpoint region using FISH techniques.
In a similar way, the breakpoint on chromosome 3pl2-pl4 may be 
mapped using YAC probes specific for this region. From this 
study, it is evident that chromosome 3 abnormalities are 
critical to the development of ovarian carcinomas and thus the 
breakpoint in the region 3pl2-pl4 also remains to be mapped 
which might permit the elucidation of a gene(s) involved in the 
initiation of these tumours and other genitourinary tumours.
The 6q- abnormality found in the fresh tumour specimen is 
equally as important in light of the frequent occurrence of this 
anomaly in ovarian tumours often as being the sole abnormality 
in several cases reported. In this study, the nature of the 6q- 
may also be elucidated using FISH techniques. The exact role 
that chromosome 6q abnormalities play in the initiation these 
cancers is unknown, however, chromosome 3 and chromosome 6 
events appear to be critical in the establishment of the 
malignant phenotype while chromosome 11 events appear to play a 
later role.
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APPENDIX A
BUFFERS
MgCl2 (1M) Dissolve 203.3g of MgCl2 .6H20 in 800ml of 
H20. Adjust the volume to 11 with H20. 
Sterilize by autoclaving
Phosphate-buffered 
saline (PBS)
Dissolve 8g NaCl, 0.2g KC1, 1.44g Na2HP04 
and 0.24g KH^PO^ in 800ml H20. Adjust the 
pH to 7.4 with HCl. Adjust the volume to 11 
with H20. Sterilize by autoclaving
2Ox SSPE buffer Dissolve 175.3g NaCl, 27.6g NaH2P04 .H20 and 
7.4g EDTA in 800ml H20. Adjust the pH to 7.4 
with NaOH and adjust the volume to 11. 
Sterilize by autoclaving
2Ox SSC buffer Dissolve 175.3g NaCl and 88,2g sodium 
citrate in 800ml H^O. Adjust the ph to 7.0 
with NaOH. Adjust the volume to 11 with H20. 
Sterilize by autoclaving
1M Tris buffer Dissolve 121.lg Tris base in 800ml H20. 
Adjust the pH to the desired reading by 
adding concentrated HC1. Adjust the volume 
to 11 with H20. Sterilize by autoclaving
50x TAE buffer Dissolve 242g Tris base, 57.1ml glacial 
acetic acid and 100ml EDTA (pH 8.0) make up 
the volume to 11 with H20. Sterilize by 
autoclaving
Phosphate buffer 
pH 6.8
Dissolve 6g KH2P04 and 5.1g of NaH2P04 .12H20 
in 11 H20.Adjust the pH to 6.8. Sterilize 
by autoclaving.
0.5M Phosphate 
buffer for FISH
Prepare 0.5M Na2HP04 .2H20 and 0.5M 
NaH2P04 .2H20 . Mix the two by using the 
latter bufrer to pH the former buffer to pH 
7.0. Sterilize by autoclaving
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STAINS AND REAGENTS
Phenol preparation
Melt the phenol at 68 °C. Add hydroxyquinolone to a final 
concentration of 0.1%.
To the melted phenol add an equal volume of buffer (0.5M Tris.HCl 
pH 8.0) at room T° . Stir the mixture on a stirrer for 15 minutes. 
Allow to settle into two phases. Aspirate the upper/aqueous phase 
using a glass pipette and discard.
Add an equal volume of 0.1M Tris.HCl pH 8.0 and repeat the above 
steps.
Repeat the above step until the pH of the phenolic phase is >7.8 
(as measured with pH paper).
Add 0.1 vol of 0.1M Tris.HCl pH 8.0 containing 0.2% £- 
mercaptoethanol and store in this form.
Paraformaldehyde 8%
Dissolve 40g of paraformaldehyde in 500ml of H^O by gently 
heating on a stirrer. Add approximately 5 drops of 10N NaOH to 
aid the dissolution. After the paraformaldehyde is dissolved, 
adjust the pH to 7.0 by the addition of HC1. Filter through 
Wattman filter paper and store at 4°C.
Trypan Blue Stain (0.2%)
Trypan blue 0.2g
PBS pH 7.4 100ml
Filtered through Wattman filter paper
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APPENDIX B
GROWTH MEDIA
Luria-Bertani broth (LB broth)
Bacto-tryptone 15g
NaCl lOg
Yeast Extract 15g
Dissolve in 11 ^ 0 .  Sterilize by autoclaving.
For the preparation of LB agar plates add 12g/l commercial agar 
before autoclaving.
AHC Medium for YAC Preparation
Yeast nitrogen base
without amino acids 0.67%
Acid-hydrolysed casein 1%
Adenine hemisulphate 20mg/l
Adjust the pH to 5.8 with about 70^1 of 12N HC1 for 1 litre. 
Sterilize by autoclaving.
To this add 50ml of 40% (w/v) D-glucose for 1 litre.
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